-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MPBiT20zrAliUET1U/iqomgDBj+Brc/472ANph+bcGhnxL7yB9LmJsPj7U6cUu9t 3dqg9sPfIwh3KYJjL+mSYA== 0000950152-07-004285.txt : 20070510 0000950152-07-004285.hdr.sgml : 20070510 20070510164135 ACCESSION NUMBER: 0000950152-07-004285 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20070331 FILED AS OF DATE: 20070510 DATE AS OF CHANGE: 20070510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTH CARE REIT INC /DE/ CENTRAL INDEX KEY: 0000766704 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 341096634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08923 FILM NUMBER: 07838519 BUSINESS ADDRESS: STREET 1: ONE SEAGATE STE 1500 STREET 2: P O BOX 1475 CITY: TOLEDO STATE: OH ZIP: 43604 BUSINESS PHONE: 4192472800 10-Q 1 l26083ae10vq.htm HEALTH CARE REIT, INC. 10-Q Health Care REIT, Inc. 10-Q
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2007
or
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File number 1-8923
HEALTH CARE REIT, INC.
(Exact name of registrant as specified in its charter)
     
Delaware   34-1096634
     
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
One SeaGate, Suite 1500, Toledo, Ohio   43604
     
(Address of principal executive office)   (Zip Code)
(419) 247-2800
(Registrant’s telephone number, including area code)
 
(Former name, former address and former fiscal year, if changed since last report)
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for at least the past 90 days.
Yes þ      No o
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer þ      Accelerated filer o      Non-accelerated filer o
     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o      No þ
     As of April 30, 2007, the registrant had 80,519,995 shares of common stock outstanding.
 
 

 


 

TABLE OF CONTENTS
             
        Page
  FINANCIAL INFORMATION        
 
           
  Financial Statements (Unaudited)        
 
           
 
  Consolidated Balance Sheets — March 31, 2007 and December 31, 2006     3  
 
           
 
  Consolidated Statements of Income — Three months ended March 31, 2007 and 2006     4  
 
           
 
  Consolidated Statements of Stockholders’ Equity — Three months ended March 31, 2007 and 2006     5  
 
           
 
  Consolidated Statements of Cash Flows — Three months ended March 31, 2007 and 2006     6  
 
           
 
  Notes to Unaudited Consolidated Financial Statements     7  
 
           
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     13  
 
           
  Quantitative and Qualitative Disclosures About Market Risk     30  
 
           
  Controls and Procedures     31  
 
           
  OTHER INFORMATION        
 
           
  Risk Factors     31  
 
           
  Other Information     31  
 
           
  Exhibits     31  
 
           
Signatures
        32  
 EX-10.3
 EX-10.4
 EX-31.1
 EX-31.2
 EX-32.1
 EX-32.2

2


Table of Contents

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
CONSOLIDATED BALANCE SHEETS
HEALTH CARE REIT, INC. AND SUBSIDIARIES
                 
    March 31,     December 31  
    2007     2006  
    (Unaudited)     (Note)  
    (In thousands)  
Assets
               
Real estate investments:
               
Real property owned
               
Land
  $ 394,002     $ 386,693  
Buildings & improvements
    3,783,163       3,659,065  
Acquired lease intangibles
    85,110       84,082  
Real property held for sale, net of accumulated depreciation
    4,236       14,796  
Construction in progress
    169,782       138,222  
 
           
 
    4,436,293       4,282,858  
Less accumulated depreciation and amortization
    (381,448 )     (347,007 )
 
           
Total real property owned
    4,054,845       3,935,851  
Loans receivable
    256,945       194,448  
Less allowance for losses on loans receivable
    (7,406 )     (7,406 )
 
           
 
    249,539       187,042  
 
           
Net real estate investments
    4,304,384       4,122,893  
Other assets:
               
Equity investments
    4,700       4,700  
Deferred loan expenses
    19,767       20,657  
Cash and cash equivalents
    31,293       36,216  
Receivables and other assets
    98,510       96,144  
 
           
 
    154,270       157,717  
 
           
Total assets
  $ 4,458,654     $ 4,280,610  
 
           
Liabilities and stockholders’ equity
               
Liabilities:
               
Borrowings under unsecured lines of credit arrangements
  $ 381,000     $ 225,000  
Senior unsecured notes
    1,542,103       1,541,814  
Secured debt
    377,013       378,972  
Liability to subsidiary trust issuing preferred securities
    52,205       52,215  
Accrued expenses and other liabilities
    95,595       101,588  
 
           
Total liabilities
    2,447,916       2,299,589  
 
               
Minority interests
    2,354       2,228  
 
               
Stockholders’ equity:
               
Preferred stock, $1.00 par value:
    338,993       338,993  
Authorized - 25,000,000 shares
               
Issued and outstanding - 13,174,989 shares at March 31, 2007 and December 31, 2006
               
Common stock, $1.00 par value:
    73,931       73,152  
Authorized - 125,000,000 shares
               
Issued - 74,195,044 shares at March 31, 2007 and 73,272,052 shares at December 31, 2006
               
Outstanding - 74,091,131 shares at March 31, 2007 and 73,192,128 at December 31, 2006
               
Capital in excess of par value
    1,902,186       1,873,811  
Treasury stock
    (3,941 )     (2,866 )
Cumulative net income
    962,526       932,853  
Cumulative dividends
    (1,267,462 )     (1,238,860 )
Accumulated other comprehensive income
    (135 )     (135 )
Other equity
    2,286       1,845  
 
           
Total stockholders’ equity
    2,008,384       1,978,793  
 
           
Total liabilities and stockholders’ equity
  $ 4,458,654     $ 4,280,610  
 
           
 
NOTE:           The consolidated balance sheet at December 31, 2006 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.
See notes to unaudited consolidated financial statements

3


Table of Contents

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES
                 
    Three Months Ended  
    March 31,  
    2007     2006  
    (In thousands, except per share data)  
Revenues:
               
Rental income
  $ 105,904     $ 71,380  
Interest income
    5,149       4,262  
Other income
    1,592       366  
 
           
 
    112,645       76,008  
 
               
Expenses:
               
Interest expense
    31,922       23,523  
Property operating expenses
    7,168       0  
Depreciation and amortization
    33,860       21,825  
General and administrative
    9,793       5,976  
Loan expense
    1,267       711  
Provision for loan losses
    0       250  
 
           
 
    84,010       52,285  
 
           
 
               
Income before minority interests
    28,635       23,723  
Minority interests
    (126 )     0  
 
           
 
               
Income from continuing operations
    28,509       23,723  
 
               
Discontinued operations:
               
Net gain (loss) on sales of properties
    977       1,553  
Income (loss) from discontinued operations, net
    187       (298 )
 
           
 
    1,164       1,255  
 
           
 
               
Net income
    29,673       24,978  
 
               
Preferred stock dividends
    6,317       5,333  
 
               
 
           
Net income available to common stockholders
  $ 23,356     $ 19,645  
 
           
 
               
Average number of common shares outstanding:
               
Basic
    73,224       58,178  
Diluted
    73,791       58,535  
 
               
Earnings per share:
               
Basic:
               
Income from continuing operations available to common stockholders
  $ 0.30     $ 0.32  
Discontinued operations, net
    0.02       0.02  
 
           
Net income available to common stockholders*
  $ 0.32     $ 0.34  
 
               
Diluted:
               
Income from continuing operations available to common stockholders
  $ 0.30     $ 0.31  
Discontinued operations, net
    0.02       0.02  
 
           
Net income available to common stockholders*
  $ 0.32     $ 0.34  
 
               
Dividends declared and paid per common share
  $ 0.2991     $ 0.6200  
 
*   Amounts may not sum due to rounding
See notes to unaudited consolidated financial statements

4


Table of Contents

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES
                                                                         
    Three Months Ended March 31, 2007
                                                    Accumulated        
                    Capital in                           Other        
    Preferred   Common   Excess of   Treasury   Cumulative   Cumulative   Comprehensive   Other    
    Stock   Stock   Par Value   Stock   Net Income   Dividends   Income   Equity   Total
     
    (In thousands)
Balances at beginning of period
  $ 338,993     $ 73,152     $ 1,873,811     $ (2,866 )   $ 932,853     $ (1,238,860 )     ($135 )   $ 1,845     $ 1,978,793  
Comprehensive income:
                                                                       
Net income
                                    29,673                               29,673  
Other comprehensive income:
                                                                    0  
 
                                                                       
Total comprehensive income
                                                                    29,673  
 
                                                                       
Proceeds from issuance of common shares from dividend reinvestment and stock incentive plans, net of forfeitures
            779       28,375       (1,075 )                             (100 )     27,979  
Compensation expense related to stock options
                                                            541       541  
Cash dividends paid:
                                                                       
Common stock-$0.2991 per share
                                            (22,285 )                     (22,285 )
Preferred stock, Series D-$0.4922 per share
                                            (1,969 )                     (1,969 )
Preferred stock, Series E-$0.3750 per share
                                            (28 )                     (28 )
Preferred stock, Series F-$0.4766 per share
                                            (3,336 )                     (3,336 )
Preferred stock, Series G-$0.4688 per share
                                            (984 )                     (984 )
     
Balances at end of period
  $ 338,993     $ 73,931     $ 1,902,186     $ (3,941 )   $ 962,526     $ (1,267,462 )   $ (135 )   $ 2,286     $ 2,008,384  
     
                                                                         
    Three Months Ended March 31, 2006
                                                    Accumulated        
                    Capital In                           Other        
    Preferred   Common   Excess of   Treasury   Cumulative   Cumulative   Comprehensive   Other    
    Stock   Stock   Par Value   Stock   Net Income   Dividends   Income   Equity   Total
     
    (In thousands)
Balances at beginning of period
  $ 276,875     $ 58,050     $ 1,306,471     $ (2,054 )   $ 830,103     $ (1,039,032 )   $ 0     $ 343     $ 1,430,756  
Comprehensive income:
                                                                       
Net income
                                    24,978                               24,978  
Other comprehensive income:
                                                                    0  
 
                                                                       
Total comprehensive income
                                                                    24,978  
 
                                                                       
Proceeds from issuance of common shares from dividend reinvestment and stock incentive plans, net of forfeitures
            635       20,391       (660 )                             (18 )     20,348  
SFAS 123(R) reclassification
                    (521 )                                     521       0  
Compensation expense related to stock options
                                                            491       491  
Cash dividends paid:
                                                                       
Common stock-$0.62 per share
                                            (36,323 )                     (36,323 )
Preferred stock, Series D-$0.4922 per share
                                            (1,969 )                     (1,969 )
Preferred stock, Series E-$0.3750 per share
                                            (28 )                     (28 )
Preferred stock, Series F-$0.4766 per share
                                            (3,336 )                     (3,336 )
     
Balances at end of period
  $ 276,875     $ 58,685     $ 1,326,341     $ (2,714 )   $ 855,081     $ (1,080,688 )   $ 0     $ 1,337     $ 1,434,917  
     
See notes to unaudited consolidated financial statements

5


Table of Contents

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES
                 
    Three Months Ended  
    March 31,  
    2007     2006  
    (In thousands)  
Operating activities
               
Net income
  $ 29,673     $ 24,978  
Adjustments to reconcile net income to net cash provided from operating activities:
               
Depreciation and amortization
    33,860       23,262  
Other amortization expenses
    1,174       693  
Capitalized interest
    (2,327 )     (665 )
Provision for loan losses
    0       250  
Stock-based compensation expense
    3,177       2,514  
Minority interests
    126       0  
Rental income less than (in excess of) cash received
    (2,613 )     7,910  
(Gain) loss on sales of properties
    (977 )     (1,553 )
Increase (decrease) in accrued expenses and other liabilities
    (3,001 )     8,809  
Decrease (increase) in receivables and other assets
    2,266       (1,645 )
 
           
Net cash provided from (used in) operating activities
    61,358       64,553  
 
               
Investing activities
               
Investment in real property
    (161,675 )     (89,994 )
Investment in loans receivable
    (80,427 )     (5,324 )
Other investments, net of payments
    (2,716 )     0  
Principal collected on loans receivable
    17,929       24,094  
Proceeds from sales of properties
    11,537       14,527  
Other
    (523 )     (496 )
 
           
Net cash provided from (used in) investing activities
    (215,875 )     (57,193 )
 
               
Financing activities
               
Net increase (decrease) under unsecured lines of credit arrangements
    156,000       6,000  
Principal payments on secured debt
    (1,894 )     (643 )
Net proceeds from the issuance of common stock
    24,467       18,985  
Decrease (increase) in deferred loan expense
    (377 )     (525 )
Cash distributions to stockholders
    (28,602 )     (41,656 )
 
           
Net cash provided from (used in) financing activities
    149,594       (17,839 )
 
           
Increase (decrease) in cash and cash equivalents
    (4,923 )     (10,479 )
Cash and cash equivalents at beginning of period
    36,216       36,237  
 
           
Cash and cash equivalents at end of period
  $ 31,293     $ 25,758  
 
           
 
               
Supplemental cash flow information-interest paid
  $ 21,934     $ 17,477  
 
           
See notes to unaudited consolidated financial statements

6


Table of Contents

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
NOTE A – Basis of Presentation
          The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered for a fair presentation have been included. Operating results for the three months ended March 31, 2007 are not necessarily an indication of the results that may be expected for the year ending December 31, 2007. For further information, refer to the financial statements and footnotes thereto included in our Annual Report on Form 10-K/A for the year ended December 31, 2006.
NOTE B – Windrose Medical Properties Trust Merger
          As discussed in our Annual Report on Form 10-K/A for the year ended December 31, 2006, we completed our merger with Windrose Medical Properties Trust on December 20, 2006. These operations are the principal component of our operating property segment (see Note M). Allocation of the purchase price has not been finalized and is subject to adjustment.
NOTE C – Real Estate Investments
          During the three months ended March 31, 2007, we invested $161,675,000 of cash in real property (including $36,162,000 of cash advances for construction in progress) and provided cash loan financings of $80,427,000. We also converted $6,921,000 of completed construction projects into operating lease properties during the three months ended March 31, 2007. As of March 31, 2007, we had $339,893,000 of unfunded construction commitments relating to existing construction in progress projects. Also during the three months ended March 31, 2007, we sold real property generating $11,537,000 of net cash proceeds and collected $17,929,000 of cash as repayment of principal on loans receivable.
NOTE D – Equity Investments
          Equity investments consist of investments in private companies where we do not have the ability to exercise influence and are accounted for under the cost method. Under the cost method of accounting, investments in private companies are carried at cost and are adjusted only for other-than-temporary declines in fair value, distributions of earnings and additional investments. For investments in public companies, if any, that have readily determinable fair market values, we classify our equity investments as available-for-sale and, accordingly, record these investments at their fair market values with unrealized gains and losses included in accumulated other comprehensive income, a separate component of stockholders’ equity. These investments represent a minimal ownership interest in these companies. In connection with the Windrose merger, we assumed a $1,000,000 investment in an unconsolidated subsidiary that holds trust preferred securities and is accounted for under the cost method.
NOTE E – Distributions Paid to Common Stockholders
          On February 20, 2007, we paid a dividend of $0.2991 per share to stockholders of record on January 31, 2007. This represents a total dividend of $0.64 per share when combined with the prorated dividend of $0.3409 per share paid on December 28, 2006 in connection with the Windrose merger. These dividends related to the period from October 1, 2006 through December 31, 2006.
NOTE F – Fair Value of Derivative Instruments
          We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We may elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. Derivatives are recorded at fair market value on the balance sheet as assets or liabilities.

7


Table of Contents

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
          On May 6, 2004, we entered into two interest rate swap agreements (the “Swaps”) for a total notional amount of $100,000,000 to hedge changes in fair value attributable to changes in the LIBOR swap rate of $100,000,000 of fixed rate debt with a maturity date of November 15, 2013. The Swaps are treated as fair-value hedges for accounting purposes and we utilize the short-cut method to assess effectiveness. The Swaps are with highly rated counterparties in which we receive a fixed rate of 6.0% and pay a variable rate based on six-month LIBOR plus a spread. At March 31, 2007, the Swaps were reported at their fair value as a $1,230,000 other asset ($902,000 other asset at December 31, 2006). For the three months ended March 31, 2007, we generated $1,000 of savings related to the Swaps that was recorded as a reduction to interest expense. For the three months ended March 31, 2006, we incurred $15,000 of losses related to the Swaps that was recorded as an addition to interest expense.
          The valuation of derivative instruments requires us to make estimates and judgments that affect the fair value of the instruments. Fair values for our derivatives are estimated by a third party consultant, which utilizes pricing models that consider forward yield curves and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates that may change in the future.
NOTE G – Discontinued Operations
          One assisted living facility was held for sale as of March 31, 2007. We did not recognize an impairment loss on this asset as the fair value less estimated costs to sell exceeded our carrying value. During the three months ended March 31, 2007, we sold two assisted living facilities with carrying values of $10,560,000 for a net gain of $977,000. In accordance with Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, we have reclassified the income and expenses attributable to all properties sold and attributable to the properties held for sale at March 31, 2007 to discontinued operations. Expenses include an allocation of interest expense based on property carrying values and our weighted average cost of debt. The following illustrates the reclassification impact of Statement No. 144 as a result of classifying properties as discontinued operations for the periods presented (in thousands):
                 
    Three Months Ended  
    March 31,  
    2007     2006  
Revenues:
               
Rental income
  $ 264     $ 2,079  
 
               
Expenses:
               
Interest expense
    77       715  
Provision for depreciation
    0       1,437  
General and administrative
    0       225  
 
               
 
           
Income (loss) from discontinued operations, net
  $ 187     $ (298 )
 
           
NOTE H – Contingent Liabilities
          We have an outstanding letter of credit issued for the benefit of certain insurance companies that provide workers’ compensation insurance to one of our tenants. Our obligation under the letter of credit matures in 2009. At March 31, 2007, our obligation under the letter of credit was $2,450,000.
          As of March 31, 2007, we had $339,893,000 of unfunded construction commitments.
NOTE I – Accumulated Other Comprehensive Income
          Accumulated other comprehensive income includes unrealized gains or losses on our equity investments and unrecognized actuarial losses from the adoption of Financial Accounting Standards No. 158, Employers Accounting for Defined Benefit Pension and Other Postretirement Plans — An amendment of FASB Statements No. 87, 88, 106 and 132(R) on December 31, 2006. These items are included as a component of stockholders’ equity. We did not recognize any comprehensive income other than the recorded net income for the three months ended March 31, 2007 or 2006.

8


Table of Contents

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
NOTE J – Earnings Per Share
          The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):
                 
    Three Months Ended  
    March 31,  
    2007     2006  
Numerator for basic and diluted earnings per share — net income available to common stockholders
  $ 23,356     $ 19,645  
 
           
 
               
Denominator for basic earnings per share — weighted average shares
    73,224       58,178  
Effect of dilutive securities:
               
Employee stock options
    178       97  
Non-vested restricted shares
    389       260  
 
           
Dilutive potential common shares
    567       357  
 
           
Denominator for diluted earnings per share — adjusted weighted average shares
    73,791       58,535  
 
           
 
               
Basic earnings per share
  $ 0.32     $ 0.34  
 
           
Diluted earnings per share
  $ 0.32     $ 0.34  
 
           
          The diluted earnings per share calculation excludes the dilutive effect of 124,000 stock options for the three months ended March 31, 2007 because the exercise prices were greater than the average market price. The diluted earnings per share calculation excludes the dilutive effect of 257,000 stock options for the three months ended March 31, 2006 because the exercise prices were greater than the average market price. The Series E Cumulative Convertible and Redeemable Preferred Stock, the Series G Cumulative Convertible Preferred Stock and the $345,000,000 senior unsecured convertible notes due December 2026 were not included in these calculations as the effect of the conversions into common stock were anti-dilutive for the relevant periods presented.
NOTE K – Other Equity
          Other equity consists of accumulated option compensation expense which represents the amount of amortized compensation costs related to stock options awarded to employees and directors subsequent to January 1, 2003. Expense, which is recognized as the options vest based on the market value at the date of the award, totaled $541,000 for the three months ended March 31, 2007 and $491,000 for the same period in 2006.
NOTE L – Stock Incentive Plans
          Our 2005 Long-Term Incentive Plan authorizes up to 2,200,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. The 2005 Plan replaced the 1995 Stock Incentive Plan and the Stock Plan for Non-Employee Directors. The options granted to officers and key employees under the 1995 Plan continue to vest through 2010 and expire ten years from the date of grant. Our non-employee directors, officers and key employees are eligible to participate in the 2005 Plan. The 2005 Plan allows for the issuance of, among other things, stock options, restricted stock, deferred stock units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares range from three years for directors to five years for officers and key employees. Options expire ten years from the date of grant.

9


Table of Contents

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
Valuation Assumptions
          The fair value of each option grant is estimated on the date of grant using the Black-Scholes-Merton option pricing model with the following weighted-average assumptions:
                 
    Three Months Ended   Three Months Ended
    March 31, 2007   March 31, 2006
Dividend yield (1)
    5.60 %     6.79 %
Expected volatility
    19.9 %     20.3 %
Risk-free interest rate
    4.74 %     4.35 %
Expected life (in years)
    5       5  
Weighted-average fair value (1)
  $ 8.31     $ 5.26  
 
(1)   Certain options granted to employees include dividend equivalent rights (“DERs”). The fair value of options with DERs also includes the net present value of projected future dividend payments over the expected life of the option discounted at the dividend yield rate.
          The dividend yield represented the dividend yield of our common stock on the dates of grant. Our computation of expected volatility was based on historical volatility. The risk-free interest rates used were the 10-year U.S. Treasury Notes yield on the dates of grant. The expected life was based on historical experience of similar awards, giving consideration to the contractual terms, vesting schedules and expectations regarding future employee behavior.
Option Award Activity
          The following table summarizes information about stock option activity for the three months ended March 31, 2007:
                                 
    Number                    
    of     Weighted     Weighted Average     Aggregate  
    Shares     Average     Remaining     Intrinsic  
Stock Options   (000’s)     Exercise Price     Contract Life (years)     Value ($000’s)  
Options at beginning of year
    917     $ 30.79       7.9          
Options granted
    124       45.73                  
Options exercised
    (332 )     28.18                  
Options terminated
    (2 )     39.67                  
 
                       
Options at end of period
    707     $ 34.61       7.7     $ 6,565  
 
                       
 
                               
Options exercisable at end of period
    325     $ 30.94       6.7     $ 4,214  
Weighted average fair value of options granted during the period
          $ 8.31                  
          The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the quoted price of our common stock for the options that were in-the-money at March 31, 2007. During the three months ended March 31, 2007, the aggregate intrinsic value of options exercised under our stock incentive plans was $5,341,000 determined as of the date of option exercise. During the three months ended March 31, 2006, the aggregate intrinsic value of options exercised under our stock incentive plans was $1,825,000 determined as of the date of option exercise. Cash received from option exercises under our stock incentive plans for the three months ended March 31, 2007 was $9,354,000. Cash received from option exercises under our stock incentive plans for the three months ended March 31, 2006 was $2,232,000.
          As of March 31, 2007, there was approximately $3,074,000 of total unrecognized compensation cost related to unvested stock options granted under our stock incentive plans. That cost is expected to be recognized over a weighted average period of three years. As of March 31, 2007, there was approximately $11,966,000 of total unrecognized compensation cost related to unvested restricted stock granted under our stock incentive plans. That cost is expected to be recognized over a weighted average period of four years.

10


Table of Contents

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
          The following table summarizes information about non-vested stock incentive awards as of March 31, 2007 and changes for the three months ended March 31, 2007:
                                 
    Stock Options     Restricted Stock  
    Number of     Weighted Average     Number of     Weighted Average  
    Shares     Grant Date     Shares     Grant Date  
    (000’s)     Fair Value     (000’s)     Fair Value  
Non-vested at December 31, 2006
    478     $ 5.35       248     $ 34.07  
Vested
    (218 )     3.78       (118 )     35.22  
Granted
    124       8.31       260       44.85  
Terminated
    (2 )     7.55       (1 )     39.36  
 
                       
Non-vested at March 31, 2007
    382     $ 7.20       389     $ 40.91  
 
                       
NOTE M – Segment Reporting
          Our business consists primarily of financing and leasing senior housing and health care real estate. We evaluate our business and make resource allocations on our two business segments — investment properties and operating properties. Under the investment property segment, we invest in senior housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our primary investment property types include skilled nursing facilities, assisted living facilities, independent living/continuing care retirement communities and specialty care facilities. Under the operating property segment, we primarily invest in medical office buildings that are typically leased under gross leases, modified gross leases or triple-net leases, to multiple tenants, and generally require a certain level of property management. The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 1 to our Annual Report on Form 10-K/A for the year ended December 31, 2006). There are no intersegment sales or transfers. We evaluate performance based upon net operating income of the combined properties in each segment.
          Non-segment revenue consists mainly of interest income on non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, accounts receivable and deferred financing costs among others. Non-property specific revenues and expenses are not allocated to individual segments in determining our performance measure.
          Summary information for the reportable segments during the three months ended March 31, 2007 and 2006 is as follows (in thousands):
                                                                         
                                    Property     Net     Real Estate              
    Rental     Interest     Other     Total     Operating     Operating     Depreciation/     Interest     Total  
    Income (1)     Income     Income     Revenues (1)     Expenses     Income (2)     Amortization (1)     Expense (1)     Assets  
Three months ended March 31, 2007:
                                                                       
Investment Properties
  $ 80,603     $ 5,149             $ 85,752             $ 85,752     $ 24,379     $ 2,310     $ 3,331,385  
Operating Properties
    25,565                       25,565     $ 7,168       18,397       9,481       4,305       972,999  
Non-segment/Corporate
                  $ 1,592       1,592                               25,384       154,270  
 
                                                     
 
  $ 106,168     $ 5,149     $ 1,592     $ 112,909     $ 7,168     $ 104,149     $ 33,860     $ 31,999     $ 4,458,654  
 
                                                     
 
                                                                       
Three months ended March 31, 2006:
                                                                       
Investment Properties
  $ 73,459     $ 4,262             $ 77,721             $ 77,721     $ 23,262     $ 1,978     $ 2,909,603  
Operating Properties
                                                                       
Non-segment/Corporate
                  $ 366       366                               22,260       103,037  
 
                                                     
 
  $ 73,459     $ 4,262     $ 366     $ 78,087     $ 0     $ 77,721     $ 23,262     $ 24,238     $ 3,012,640  
 
                                                     
 
(1)   Includes amounts from discontinued operations.
 
(2)   Net operating income (“NOI”) is used to evaluate the operating performance of certain real estate properties such as medical office buildings. We define NOI as rental revenues, including tenant reimbursements, less property level operating expenses, which exclude depreciation and amortization, general and administrative expenses, impairments, interest expense and discontinued operations. We believe NOI provides investors relevant and useful information because it measures the operating performance of our medical office buildings at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our medical office buildings.

11


Table of Contents

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
NOTE N – New Accounting Pronouncements
          On January 1, 2007, we adopted Financial Accounting Standards Board (“FASB”) Interpretation No. 48, Accounting for Uncertainty in Income Taxes. The Interpretation clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements in accordance with Statement of Financial Accounting Standards No. 109, Accounting for Income Taxes. The Interpretation prescribes guidance for recognizing, measuring, reporting and disclosing a tax position taken or expected to be taken in a tax return. The adoption of the Interpretation did not have a material impact on our financial position or results of operations.
          In September 2006, the FASB also issued Statement of Financial Accounting Standards No. 157, Fair Value Measurements (“SFAS 157”), which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. SFAS 157 will be effective for fiscal year 2007. Adoption of SFAS 157 is not expected to have a material impact on our financial position, although additional disclosures may be required.
          In February 2007, the FASB issued Statement of Financial Accounting Standards No. 159, The Fair Value Option for Financial Assets and Financial Liabilities (“SFAS 159”), which permits companies to elect to measure certain eligible items at fair value. Subsequent unrealized gains and losses on those items will be reported in earnings. Upfront costs and fees related to those items will be reported in earnings as incurred and not deferred. SFAS 159 is effective for fiscal years beginning after November 15, 2007. If a company elects to apply the provisions of the SFAS 159 to eligible items existing at that date, the effect of the remeasurement to fair value will be reported as a cumulative effect adjustment to the opening balance of retained earnings. Retrospective application will not be permitted. We are currently assessing whether we will elect to use the fair value option for any eligible items.
NOTE O – Significant Changes and Events
Common Stock Issuance
          On April 18, 2007, we completed a public offering of 6,325,000 shares of common stock with net proceeds to the company of approximately $265,337,000.
Line of Credit Extension
          Subsequent to March 31, 2007, we extended the maturity of our $40,000,000 unsecured line of credit arrangement from May 31, 2007 to May 30, 2008 and reduced the pricing from 0.9% to 0.8% over LIBOR interest rate.
Rendina/Paramount Acquisition
          On January 11, 2007, we announced an agreement to purchase a portfolio of medical office buildings from affiliates of Rendina Companies. As part of the transaction, we also agreed to acquire Paramount Real Estate Services, the property management group of Rendina Companies. The property portfolio includes 17 medical office buildings in ten states. The transactions are anticipated to close in the second quarter of 2007.

12


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
          The following discussion and analysis is based primarily on the consolidated financial statements of Health Care REIT, Inc. for the periods presented and should be read together with the notes thereto contained in this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K/A for the year ended December 31, 2006, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Executive Overview
Business
          Health Care REIT, Inc. is a self-administered, equity real estate investment trust that invests in the full spectrum of senior housing and health care real estate. Founded in 1970, we were the first REIT to invest exclusively in health care facilities. The following table summarizes our portfolio as of March 31, 2007:
                                                                         
    Investments (1)     Percentage of     Revenues (2)     Percentage of     Number of     # Beds/Units     Investment per     Operators/        
Type of Property   (in thousands)     Investments     (in thousands)     Revenues (2)     Properties     or Sq. Ft.     metric (3)     Tenants     States  
Independent living/CCRCs
  $ 550,462       13 %   $ 10,223       9 %     48     5,685 units   $129,977 per unit     20       20  
 
                                                                       
Assisted living facilities
    1,045,546       24 %     26,528       23 %     208     12,590 units   91,598 per unit     26       33  
 
                                                                       
Skilled nursing facilities
    1,547,904       36 %     43,494       39 %     233     31,668 beds   49,233 per bed     22       28  
 
                                                                       
Medical office buildings
    899,599       21 %     23,788       21 %     90     3,317,476 sq. ft.   271 per sq. ft.     636       13  
 
                                                                       
Specialty care facilities
    270,729       6 %     7,284       7 %     18     1,391 beds   218,044 per bed     9       9  
 
                                                                       
Other income
                    1,592       1 %                                        
 
                                                             
 
                                                                       
Totals
  $ 4,314,240       100 %   $ 112,909       100 %     597                                  
 
                                                             
 
(1)   Investments include gross real estate investments and credit enhancements which amounted to $4,311,790,000 and $2,450,000, respectively.
 
(2)   Revenues include gross revenues and revenues from discontinued operations for the three months ended March 31, 2007.
 
(3)   Investment per Bed/Unit was computed by using the total investment amount of $4,654,133,000 which includes gross real estate investments, credit enhancements and unfunded construction commitments for which initial funding has commenced which amounted to $4,311,790,000, $2,450,000 and $339,893,000, respectively.
          Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in rental and interest income and portfolio growth. To meet these objectives, we invest across the full spectrum of senior housing and health care real estate and diversify our investment portfolio by property type, operator/tenant and geographic location.
          Substantially all of our revenues and sources of cash flows from operations are derived from operating lease rentals and interest earned on outstanding loans receivable. These items represent our primary source of liquidity to fund distributions and are dependent upon our obligors’ continued ability to make contractual rent and interest payments to us. To the extent that our obligors experience operating difficulties and are unable to generate sufficient cash to make payments to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property and operator/tenant. Our asset management process includes review of monthly financial statements for each property, periodic review of obligor credit, periodic property inspections and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. In monitoring our portfolio, our personnel use a proprietary database to collect and analyze property-specific data. Additionally, we conduct extensive research to ascertain industry trends and risks. Through these asset management and research efforts, we are typically able to intervene at an early stage to address payment risk, and in so doing, support both the collectibility of revenue and the value of our investment.
          In addition to our asset management and research efforts, we also structure our investments to help mitigate payment risk. We typically limit our investments to no more than 90% of the appraised value of a property. Operating leases and loans are normally credit enhanced by guaranties and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other loans, operating leases or agreements between us and the obligor and its affiliates.
          For the three months ended March 31, 2007, rental income and interest income represented 94% and 5%, respectively, of total gross revenues (including revenues from discontinued operations). Substantially all of our operating leases are designed with either fixed

13


Table of Contents

or contingent escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectibility assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.
          Depending upon the availability and cost of external capital, we anticipate investing in additional properties. New investments are generally funded from temporary borrowings under our unsecured lines of credit arrangements, internally generated cash and the proceeds from sales of real property. Our investments generate internal cash from rent and interest receipts and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under the unsecured lines of credit arrangements, is expected to be provided through a combination of public and private offerings of debt and equity securities and the incurrence or assumption of secured debt. We believe our liquidity and various sources of available capital are sufficient to fund operations, meet debt service obligations (both principal and interest), make dividend distributions and finance future investments.
          Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. During the three months ended March 31, 2007, we completed $243,657,000 of gross new investments and had $24,742,000 of investment payoffs, resulting in net investments of $218,915,000. We expect to complete gross new investments of $1.0 billion to $1.2 billion during 2007, including acquisitions of approximately $700,000,000 to $800,000,000 and funded new development of approximately $300,000,000 to $400,000,000. We anticipate the sale of real property and the repayment of loans receivable totaling approximately $100,000,000 to $200,000,000 resulting in net new investments of $800,000,000 to $1.1 billion during 2007. It is possible that additional loan repayments or sales of real property may occur in the future. To the extent that loan repayments and real property sales exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any loan repayments and real property sales in new investments. To the extent that new investment requirements exceed our available cash on hand, we expect to borrow under our unsecured lines of credit arrangements. At March 31, 2007, we had $31,293,000 of cash and cash equivalents and $359,000,000 of available borrowing capacity under our unsecured lines of credit arrangements.
Windrose Medical Properties Trust Merger
          As discussed in our Annual Report on Form 10-K/A for the year ended December 31, 2006, we completed our merger with Windrose Medical Properties Trust on December 20, 2006. These operations are the principal component of our operating property segment (see Note M to our unaudited consolidated financial statements). The results of operations for this segment represent the primary change in our consolidated results of operations from the prior year. Allocation of the purchase price has not been finalized and is subject to adjustment.
Rendina/Paramount Acquisition
          On January 11, 2007, we announced an agreement to purchase a portfolio of medical office buildings from affiliates of Rendina Companies. As part of the transaction, we also agreed to acquire Paramount Real Estate Services, the property management group of Rendina Companies. The property portfolio includes 17 medical office buildings in ten states. The transactions are anticipated to close in the second quarter of 2007.
Key Transactions in 2007
          We have completed the following key transactions to date in 2007:
    our Board of Directors increased our quarterly dividend to $0.66 per share, which represents a two cent increase from the quarterly dividend of $0.64 paid for 2006. The dividend declared for the quarter ended March 31, 2007 represents the 144th consecutive dividend payment;
 
    we completed $243,657,000 of gross investments and had $24,742,000 of investment payoffs during the three months ended March 31, 2007;
 
    we completed a public offering of 6,325,000 shares of common stock with net proceeds to the company of approximately $265,337,000 in April 2007; and
 
    we extended our $40,000,000 unsecured line of credit which was scheduled to mature in May 2007 to May 2008 and reduced pricing by 10 basis points.
Key Performance Indicators, Trends and Uncertainties
          We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, concentration risk and credit strength. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.
          Operating Performance. We believe that net income available to common stockholders (“NICS”) is the most appropriate earnings measure. Other useful supplemental measures of our operating performance include funds from operations (“FFO”) and funds available for distribution (“FAD”); however, these supplemental measures are not defined by U.S. generally accepted accounting

14


Table of Contents

principles (“U.S. GAAP”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion of FFO and FAD and for reconciliations of FFO and FAD to NICS. These earnings measures and their relative per share amounts are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies. The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands, except per share data):
                                         
    Three Months Ended
    March 31,   June 30,   September 30,   December 31,   March 31,
    2006   2006   2006   2006   2007
     
Net income (loss) available to common stockholders
  $ 19,645     $ 22,668     $ 21,480     $ 17,494     $ 23,356  
Funds from operations
    41,354       45,870       45,898       44,459       56,207  
Funds available for distribution
    49,975       47,071       48,032       46,809       53,825  
 
                                       
Per share data (fully diluted):
                                       
Net income (loss) available to   common stockholders
  $ 0.34     $ 0.37     $ 0.34     $ 0.27     $ 0.32  
Funds from operations
    0.71       0.74       0.73       0.69       0.76  
Funds available for distribution
    0.85       0.76       0.76       0.72       0.73  
          Concentration Risk. We evaluate our concentration risk in terms of asset mix, investment mix, customer mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our investments could be at risk if certain sectors were to experience downturns. Asset mix measures the portion of our investments that are real property. In order to qualify as an equity REIT, at least 75% of our real estate investments must be real property whereby each property, which includes the land, buildings, improvements, intangibles and related rights, is owned by us and leased to a tenant pursuant to a long-term operating lease. Investment mix measures the portion of our investments that relate to our various property types. Customer mix measures the portion of our investments that relate to our top five customers. Geographic mix measures the portion of our investments that relate to our top five states. The following table reflects our recent historical trends of concentration risk for the periods presented:
                                         
    March 31,   June 30,   September 30,   December 31,   March 31,
    2006   2006   2006   2006   2007
     
Asset mix:
                                       
Real property
    94 %     94 %     93 %     95 %     94 %
Loans receivable
    6 %     6 %     7 %     5 %     6 %
 
                                       
Investment mix:
                                       
Independent living/CCRCs
    15 %     15 %     16 %     13 %     13 %
Assisted living facilities
    33 %     33 %     32 %     25 %     24 %
Skilled nursing facilities
    45 %     45 %     46 %     34 %     36 %
Medical office buildings
                            22 %     21 %
Specialty care facilities
    7 %     7 %     6 %     6 %     6 %
 
                                       
Customer mix:
                                       
Emeritus Corporation
    12 %     12 %     11 %     9 %     8 %
Brookdale Senior Living Inc.
    10 %     10 %     9 %     7 %     7 %
Home Quality Management, Inc.
                    8 %     6 %     6 %
Life Care Centers of America, Inc.
    7 %     8 %     7 %     6 %     6 %
Merrill Gardens L.L.C.
    7 %     7 %     6 %     4 %     4 %
Tara Cares, LLC.
            6 %                        
Delta Health Group, Inc.
    6 %                                
Remaining operators
    58 %     57 %     59 %     68 %     69 %
 
                                       
Geographic mix:
                                       
Florida
    14 %     14 %     15 %     17 %     16 %
Texas
    8 %     8 %     8 %     11 %     13 %
Massachusetts
    12 %     11 %     11 %     8 %     8 %
California
                            7 %     7 %
Ohio
    9 %     9 %     8 %     6 %     6 %
North Carolina
    7 %     7 %     6 %                
Remaining states
    50 %     51 %     52 %     51 %     50 %

15


Table of Contents

          Credit Strength. We measure our credit strength both in terms of leverage ratios and coverage ratios. Our leverage ratios include debt to book capitalization and debt to market capitalization. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt. The coverage ratios indicate our ability to service interest and fixed charges (interest, secured debt principal amortization and preferred dividends). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain investment grade ratings with Moody’s Investors Service, Standard & Poor’s Ratings Services and Fitch Ratings. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization (“EBITDA”) which is discussed in further detail, and reconciled to net income, below in “Non-GAAP Financial Measures.” Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented:
                                         
    Three Months Ended
    March 31,   June 30,   September 30,   December 31,   March 31,
    2006   2006   2006   2006   2007
     
Debt to book capitalization ratio
    52 %     49 %     51 %     53 %     54 %
Debt to market capitalization ratio
    38 %     37 %     36 %     39 %     40 %
 
                                       
Interest coverage ratio
    2.99 x     3.16 x     2.98 x     2.75 x     2.82 x
Fixed charge coverage ratio
    2.41 x     2.52 x     2.41 x     2.23 x     2.28 x
          We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in “Forward-Looking Statements and Risk Factors” and other sections of this Quarterly Report on Form 10-Q. Management regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our Annual Report on Form 10-K/A for the year ended December 31, 2006, under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussion of these risk factors.
Portfolio Update
          Investment Properties. Payment coverages of the operators in our investment property portfolio continue to remain strong. Our overall payment coverage is at 1.94 times, which is consistent with the prior year. The table below reflects our recent historical trends of portfolio coverages. Coverage data reflects the 12 months ended for the periods presented. CBMF represents the ratio of facilities’ earnings before interest, taxes, depreciation, amortization, rent and management fees to contractual rent or interest due us. CAMF represents the ratio of earnings before interest, taxes, depreciation, amortization, and rent (but after imputed management fees) to contractual rent or interest due us.
                                                 
    December 31, 2004   December 31, 2005   December 31, 2006
    CBMF   CAMF   CBMF   CAMF   CBMF   CAMF
Independent living/CCRCs (1)
                    1.45 x     1.23 x     1.39 x     1.19 x
Assisted living facilities
    1.47 x     1.25 x     1.52 x     1.30 x     1.56 x     1.35 x
Skilled nursing facilities
    2.15 x     1.64 x     2.21 x     1.63 x     2.19 x     1.57 x
Specialty care facilities
    3.00 x     2.37 x     3.19 x     2.60 x     2.77 x     2.21 x
 
                                               
Weighted averages
    1.84 x     1.48 x     1.94 x     1.54 x     1.94 x     1.51 x
 
(1)   As a result of our significant independent living/continuing care retirement community acquisitions in the fourth quarter of 2005, we began to separately disclose this facility classification in our portfolio reporting. We adopted the National Investment Center definitions and reclassified certain of our existing facilities to this classification.
          Operating Properties. The primary performance measure for our operating properties is net operating income (“NOI”) as discussed below in Non-GAAP Financial Measures. For the three months ended March 31, 2007, our operating properties generated $18,397,000 of net operating income which represents $25,565,000 of rental income less $7,168,000 of property operating expenses.

16


Table of Contents

Corporate Governance
          Maintaining investor confidence and trust has become increasingly important in today’s business environment. Health Care REIT, Inc.’s Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. In March 2004, the Board of Directors adopted its Corporate Governance Guidelines. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on our Web site at www.hcreit.com and from us upon written request sent to the Senior Vice President – Administration and Corporate Secretary, Health Care REIT, Inc., One SeaGate, Suite 1500, P.O. Box 1475, Toledo, Ohio 43603-1475.
Liquidity and Capital Resources
Sources and Uses of Cash
          Our primary sources of cash include rent and interest receipts, borrowings under unsecured lines of credit arrangements, public and private offerings of debt and equity securities, proceeds from the sales of real property and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including construction advances), loan advances and general and administrative expenses. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below.
          The following is a summary of our sources and uses of cash flows (dollars in thousands):
                                 
    Three Months Ended     Change  
    Mar. 31, 2007     Mar. 31, 2006     $     %  
Cash and cash equivalents at beginning of period
  $ 36,216     $ 36,237     $ (21 )     0 %
Cash provided from (used in) operating activities
    61,358       64,553       (3,195 )     -5 %
Cash provided from (used in) investing activities
    (215,875 )     (57,193 )     (158,682 )     277 %
Cash provided from (used in) financing activities
    149,594       (17,839 )     167,433       n/a  
 
                       
Cash and cash equivalents at end of period
  $ 31,293     $ 25,758     $ 5,535       21 %
 
                       
          Operating Activities. The change in net cash provided from operating activities is primarily attributable to an increase in net income and to changes in receivables/other assets and accruals/other liabilities. The increase in net income is discussed below in “Results of Operations.”
          The following is a summary of our straight-line rent (dollars in thousands):
                                 
    Three Months Ended     Change  
    Mar. 31, 2007     Mar. 31, 2006     $     %  
Gross straight-line rental income
  $ 4,231     $ 2,400     $ 1,831       76 %
Cash receipts due to real property sales
    0       (604 )     604       -100 %
Prepaid rent receipts
    (2,078 )     (9,706 )     7,628       -79 %
Rental income related to above/below market leases
    460       0       460       n/a  
 
                       
Cash receipts less than (in excess of) rental income
  $ 2,613     $ (7,910 )   $ 10,523       n/a  
 
                       
     Gross straight-line rental income represents the non-cash difference between contractual cash rent due and the average rent recognized pursuant to Statement of Financial Accounting Standards No. 13, Accounting for Leases (“SFAS 13”), for leases with fixed rental escalators, net of collectibility reserves. This amount is positive in the first half of a lease term (but declining every year due to annual increases in cash rent due) and is negative in the second half of a lease term. The increase in gross straight-line rental income is primarily attributable to leases in our operating properties segment, assumed in connection with the Windrose merger on December 20, 2006. The decrease in prepaid rent receipts is primarily attributable to cash received in connection with the acquisition of Commonwealth Communities Holdings LLC by Kindred Healthcare, Inc. in February 2006 as discussed in our Annual Report on Form 10-K for the year ended December 31, 2005.

17


Table of Contents

          Investing Activities. The changes in net cash used in investing activities are primarily attributable to net changes in real property and loans receivable. The following is a summary of our investment and disposition activities (dollars in thousands):
                                 
    Three Months Ended  
    Mar. 31, 2007     Mar. 31, 2006  
    Facilities     Amount     Facilities     Amount  
Real property acquisitions:
                               
Assisted living facilities
    2     $ 9,875       2     $ 6,150  
Skilled nursing facilities
    7       103,300       8       71,020  
Medical office buildings
    1       7,999                  
Land parcels
                            3,274  
 
                       
Total acquisitions
    10       121,174       10       80,444  
Less: Assumed debt
                            (25,049 )
 
                           
Cash disbursed for acquisitions
            121,174               55,395  
Construction in progress cash advances
            36,162               31,912  
Capital improvements to existing properties
            4,339               2,687  
 
                           
Total cash invested in real property
            161,675               89,994  
 
                               
Real property dispositions:
                               
Assisted living facilities
    2       11,537       1       13,396  
Skilled nursing facilities
                    1       1,081  
Land parcels
                            50  
 
                       
Proceeds from real property sales
    2       11,537       2       14,527  
 
                       
Net cash investments in real property
    8     $ 150,138       8     $ 75,467  
 
                       
 
                               
Advances on loans receivable:
                               
Investments in new loans
          $ 69,546             $ 4,250  
Draws on existing loans
            10,881               1,074  
 
                           
Total investments in loans
            80,427               5,324  
 
                               
Receipts on loans receivable:
                               
Loan payoffs
            14,182               21,240  
Principal payments on loans
            3,747               2,854  
 
                           
Total principal receipts on loans
            17,929               24,094  
 
                           
Net cash advances (receipts) on loans receivable
          $ 62,498             $ (18,770 )
 
                           
          Financing Activities. The changes in net cash provided from or used in financing activities are primarily attributable to changes related to our unsecured lines of credit arrangements and cash distributions to stockholders.
          For the three months ended March 31, 2007, we had a net increase of $156,000,000 on our unsecured lines of credit arrangements as compared to a net increase of $6,000,000 for the same period in 2006.
          In order to qualify as a REIT for federal income tax purposes, we must distribute at least 90% of our taxable income (including 100% of capital gains) to our stockholders. The decrease in dividends is primarily attributable to a decrease in our common stock dividends due to the payment of prorated dividends of $0.2991 in February 2007 and $0.3409 in December 2006 in conjunction with the Windrose merger.
          The following is a summary of our dividend payments (in thousands, except per share amounts):
                                 
    Three Months Ended  
    Mar. 31, 2007     Mar. 31, 2006  
    Per Share     Amount     Per Share     Amount  
Common Stock
  $ 0.2991     $ 22,285     $ 0.6200     $ 36,323  
Series D Preferred Stock
    0.4922       1,969       0.4922       1,969  
Series E Preferred Stock
    0.3750       28       0.3750       28  
Series F Preferred Stock
    0.4766       3,336       0.4766       3,336  
Series G Preferred Stock
    0.4688       984               0  
 
                           
Totals
          $ 28,602             $ 41,656  
 
                           

18


Table of Contents

Off-Balance Sheet Arrangements
          We have an outstanding letter of credit issued for the benefit of certain insurance companies that provide workers’ compensation insurance to one of our tenants. Our obligation under the letter of credit matures in 2009. At March 31, 2007, our obligation under the letter of credit was $2,450,000.
          We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on the general trend in interest rates at the applicable dates, our perception of the future volatility of interest rates and our relative levels of variable rate debt and variable rate investments. As of March 31, 2007, we participated in two interest rate swap agreements related to our long-term debt. Our interest rate swaps are discussed below in “Contractual Obligations.”
Contractual Obligations
          The following table summarizes our payment requirements under contractual obligations as of March 31, 2007 (in thousands):
                                         
    Payments Due by Period  
Contractual Obligations   Total     2007     2008-2009     2010-2011     Thereafter  
Unsecured lines of credit arrangements (1)
  $ 740,000     $ 40,000     $ 700,000     $ 0     $ 0  
Senior unsecured notes (2)
    1,539,830       52,500       42,330               1,445,000  
Secured debt (2)
    376,506       17,449       85,530       62,289       211,238  
Trust preferred liability (2)
    51,000                               51,000  
Contractual interest obligations
    1,107,270       124,907       269,884       218,404       494,075  
Capital lease obligations
    0                                  
Operating lease obligations
    36,651       2,029       4,664       4,005       25,953  
Purchase obligations
    375,525       57,621       269,966       47,938          
Other long-term liabilities
    0                                  
 
                             
Total contractual obligations
  $ 4,226,782     $ 294,506     $ 1,372,374     $ 332,636     $ 2,227,266  
 
                             
 
(1)   Unsecured lines of credit arrangements reflected at 100% capacity.
 
(2)   Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
          At March 31, 2007, we had an unsecured credit arrangement with a consortium of twelve banks providing for a revolving line of credit (“revolving credit”) in the amount of $700,000,000, which is scheduled to expire on July 26, 2009. Borrowings under the agreement are subject to interest payable in periods no longer than three months at either the agent bank’s prime rate of interest or the applicable margin over LIBOR interest rate, at our option (6.175% at March 31, 2007). The applicable margin is based on our ratings with Moody’s Investors Service and Standard & Poor’s Ratings Services and was 0.8% at March 31, 2007. In addition, we pay a facility fee annually to each bank based on the bank’s commitment under the revolving credit facility. The facility fee depends on our ratings with Moody’s Investors Service and Standard & Poor’s Ratings Services and was 0.15% at March 31, 2007. We also pay an annual agent’s fee of $50,000. Principal is due upon expiration of the agreement. We have another unsecured line of credit arrangement with a bank for a total of $40,000,000, which was scheduled to expire May 31, 2007. Borrowings under this line of credit are subject to interest at either the bank’s prime rate of interest (8.25% at March 31, 2007) or 0.9% over LIBOR interest rate, at our option. Principal is due upon expiration of the agreement. Subsequent to March 31, 2007, we extended this agreement to May 30, 2008 and reduced the pricing to 0.8% over LIBOR interest rate. At March 31, 2007, we had $381,000,000 outstanding under the unsecured lines of credit arrangements and estimated total contractual interest obligations of $54,896,000. Contractual interest obligations are estimated based on the assumption that the balance of $381,000,000 at March 31, 2007 is constant until maturity at interest rates in effect at March 31, 2007.
          We have $1,539,830,000 of senior unsecured notes principal outstanding with fixed annual interest rates ranging from 4.75% to 8.0%, payable semi-annually. Total contractual interest obligations on senior unsecured notes totaled $874,893,000 at March 31, 2007. Additionally, we have mortgage loans with total outstanding principal of $376,506,000, collateralized by owned properties, with fixed annual interest rates ranging from 4.89% to 8.5%, payable monthly. The carrying values of the properties securing the mortgage loans totaled $740,658,000 at March 31, 2007. Total contractual interest obligations on mortgage loans totaled $135,313,000 at March 31, 2007.
          On May 6, 2004, we entered into two interest rate swap agreements (the “Swaps”) for a total notional amount of $100,000,000 to hedge changes in fair value attributable to changes in the LIBOR swap rate of $100,000,000 of fixed rate debt with a maturity date of November 15, 2013. The Swaps are treated as fair-value hedges for accounting purposes and we utilize the short-cut method to assess effectiveness. The Swaps are with highly rated counterparties in which we receive a fixed rate of 6.0% and pay a variable rate based on six-month LIBOR plus a spread. At March 31, 2007, total contractual interest obligations were estimated to be $42,168,000.

19


Table of Contents

          At March 31, 2007, we had operating lease obligations of $36,651,000 relating to ground leases at certain of our properties and office space leases.
          Purchase obligations are comprised of unfunded construction commitments and contingent purchase obligations. At March 31, 2007, we had outstanding construction financings of $169,782,000 for leased properties and were committed to providing additional financing of approximately $339,893,000 to complete construction. At March 31, 2007, we had contingent purchase obligations totaling $35,632,000. These contingent purchase obligations primarily relate to deferred acquisition fundings and capital improvements. Deferred acquisition fundings are contingent upon a tenant satisfying certain conditions in the lease. Upon funding, amounts due from the tenant are increased to reflect the additional investment in the property.
Capital Structure
          As of March 31, 2007, we had stockholders’ equity of $2,008,384,000 and a total outstanding debt balance of $2,352,321,000, which represents a debt to total book capitalization ratio of 54%. Our ratio of debt to market capitalization was 40% at March 31, 2007. For the three months ended March 31, 2007, our interest coverage ratio was 2.82 to 1.00. For the three months ended March 31, 2007, our fixed charge coverage ratio was 2.28 to 1.00. Also, at March 31, 2007, we had $31,293,000 of cash and cash equivalents and $359,000,000 of available borrowing capacity under our unsecured lines of credit arrangements.
          Our debt agreements contain various covenants, restrictions and events of default. Among other things, these provisions require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2007, we were in compliance with all of the covenants under our debt agreements. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings. However, under our unsecured lines of credit arrangements, the ratings on our senior unsecured notes are used to determine the fees and interest payable.
          As of April 30, 2007, our senior unsecured notes were rated Baa2 (stable), BBB- (positive) and BBB- (stable) by Moody’s Investors Service, Standard & Poor’s Ratings Services and Fitch Ratings, respectively. We plan to manage the company to maintain investment grade status with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the noted rating agencies could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.
          On May 12, 2006, we filed an open-ended automatic or “universal” shelf registration statement with the Securities and Exchange Commission covering an indeterminate amount of future offerings of debt securities, common stock, preferred stock, depositary shares, warrants and units. As of April 30, 2007, we had an effective registration statement on file in connection with our enhanced DRIP program under which we may issue up to 6,314,213 shares of common stock. As of April 30, 2007, 760,247 shares of common stock remained available for issuance under this registration statement. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our unsecured lines of credit arrangements.
Results of Operations
          Net income available to common stockholders for the three months ended March 31, 2007 totaled $23,356,000, or $0.32 per diluted share, as compared with $19,645,000, or $0.34 per diluted share, for the same period in 2006. Net income available to common stockholders increased from the prior year primarily due to an increase in rental income offset by increases in interest expense, provisions for depreciation and amortization, property operating expenses and general and administrative expenses. These items are discussed in further detail below.
          FFO for the three months ended March 31, 2007 totaled $56,207,000, or $0.76 per diluted share, as compared with $41,354,000, or $0.71 per diluted share, for the same period in 2006. FAD for the three months ended March 31, 2007 totaled $53,825,000, or $0.73 per diluted share, as compared to $49,975,000, or $0.85 per diluted share, for the same period in 2006. The increase in FFO is due primarily to an increase in rental income offset by increases in interest expense, property operating expenses and general and administrative expenses. The increase in FAD is primarily due to the items noted above for FFO and the change in net straight-line rental income. Please refer to the discussion of “Non-GAAP Financial Measures” below for further information regarding FFO and FAD and for reconciliations of FFO and FAD to NICS.
          EBITDA for the three months ended March 31, 2007 totaled $96,810,000, as compared with $73,189,000 for the same period in 2006. Our interest coverage ratio was 2.82 times for the three months ended March 31, 2007 as compared with 2.99 times for the same period in 2006. Our fixed charge coverage ratio was 2.28 times for the three months ended March 31, 2007 as compared with 2.41 times for the same period in 2006. The increase in EBITDA is primarily due to the increase in rental income offset by increases in property operating expenses and general and administrative expenses. The decrease in our interest coverage ratio is primarily due to the increase in

20


Table of Contents

interest expense. The decrease in our fixed charge coverage ratio is primarily due to the increases in interest expense, preferred dividends and secured debt principal amortization payments. These items are discussed in further detail below. Please refer to the discussion of “Non-GAAP Financial Measures” below for further information regarding EBITDA and a reconciliation of EBITDA to net income.
          Revenues were comprised of the following (dollars in thousands):
                                 
    Three Months Ended     Change  
    Mar. 31, 2007     Mar. 31, 2006     $     %  
Rental income
  $ 105,904     $ 71,380     $ 34,524       48 %
Interest income
    5,149       4,262       887       21 %
Transaction fees and other income
    1,592       366       1,226       335 %
 
                       
Totals
  $ 112,645     $ 76,008     $ 36,637       48 %
 
                       
          The increase in gross revenues is primarily attributable to increased rental income resulting from the acquisitions of new properties from which we receive rent. See the discussion of investing activities in “Liquidity and Capital Resources” above for further information. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If gross operating revenues at our facilities and/or the Consumer Price Index do not increase, a portion of our revenues may not continue to increase. Sales of real property would offset revenue increases and, to the extent that they exceed new acquisitions, could result in decreased revenues. Our leases could renew above or below current rent rates, resulting in an increase or decrease in rental income.
          Interest income increased from 2006 primarily due to an increase in the balance of outstanding loans. Transaction fees and other income increased for the year primarily due to the receipt of $950,000 from non-recurring fees.
          Expenses were comprised of the following (dollars in thousands):
                                 
    Three Months Ended     Change  
    Mar. 31, 2007     Mar. 31, 2006     $     %  
Interest expense
  $ 31,922     $ 23,523     $ 8,399       36 %
Property operating expenses
    7,168       0       7,168       n/a  
Depreciation and amortization
    33,860       21,825       12,035       55 %
General and administrative
    9,793       5,976       3,817       64 %
Loan expense
    1,267       711       556       78 %
Provision for loan losses
    0       250       (250 )     -100 %
 
                       
Totals
  $ 84,010     $ 52,285     $ 31,725       61 %
 
                       
          The following is a summary of our interest expense (dollars in thousands):
                                 
    Three Months Ended     Change  
    Mar. 31, 2007     Mar. 31, 2006     $     %  
Senior unsecured notes
  $ 23,671     $ 19,574     $ 4,097       21 %
Secured debt
    5,694       1,978       3,716       188 %
Unsecured lines of credit
    4,041       2,873       1,168       41 %
Subsidiary trust liability
    921       0       921       n/a  
Capitalized interest
    (2,327 )     (202 )     (2,125 )     1,052 %
SWAP losses (savings)
    (1 )     15       (16 )     n/a  
Discontinued operations
    (77 )     (715 )     638       -89 %
 
                       
Totals
  $ 31,922     $ 23,523     $ 8,399       36 %
 
                       
          The increase in interest expense on senior unsecured notes is due to higher average borrowings offset by lower average interest rates. For the three months ended March 31, 2007, we had $1,539,830,000 of senior unsecured notes principal outstanding with a

21


Table of Contents

weighted average interest rate of 6.159% compared to $1,194,830,000 and 6.566% for the prior year. The changes from the prior year are due to the issuance of $345,000,000 4.75% senior unsecured convertible notes in November 2006.
          The change in interest expense on secured debt is due to the net effect and timing of assumptions, extinguishments and principal amortizations. The increased balance from the prior year is due to the assumption of $248,844,000 of secured debt outstanding principal in connection with the Windrose merger in December 2006. The following is a summary of our secured debt principal activity (dollars in thousands):
                                 
    Three Months Ended     Three Months Ended  
    March 31, 2007     March 31, 2006  
            Weighted Avg.             Weighted Avg.  
    Amount     Interest Rate     Amount     Interest Rate  
Beginning balance
  $ 378,400       6.406 %   $ 107,540       7.328 %
Debt assumed
                    25,049       6.315 %
Principal payments
    (1,894 )     6.507 %     (643 )     7.389 %
 
                       
Ending balance
  $ 376,506       6.347 %   $ 131,946       7.135 %
 
                       
 
                               
Monthly averages
  $ 377,476       6.348 %   $ 113,482       7.272 %
          The change in interest expense on unsecured lines of credit arrangements is due primarily to the net effect and timing of average draws, paydowns and variable interest rate changes. The following is a summary of our unsecured lines of credit arrangements (dollars in thousands):
                 
    Three Months Ended March 31,
    2007   2006
Balance outstanding at quarter end
  $ 381,000     $ 201,000  
Maximum amount outstanding at any month end
  $ 381,000     $ 201,000  
Average amount outstanding (total of daily principal balances divided by days in period)
  $ 243,650     $ 184,367  
Weighted average interest rate (actual interest expense divided by average borrowings outstanding)
    6.63 %     6.23 %
          We have a $51,000,000 liability to a subsidiary trust issuing trust preferred securities that was assumed in the Windrose merger in December 2006. The trust preferred securities mature on March 30, 2036, are redeemable at our option beginning March 30, 2011, and require quarterly distributions of interest to the holders of the trust preferred securities. The trust preferred securities bear a fixed rate per annum equal to 7.22% through March 30, 2011, and a variable rate per annum equal to LIBOR plus 2.05% thereafter.
          We capitalize certain interest costs associated with funds used to finance the construction of properties owned directly by us. The amount capitalized is based upon the borrowings outstanding during the construction period using the rate of interest that approximates our cost of financing. Our interest expense is reduced by the amount capitalized. Capitalized interest for the three months ended March 31, 2007 totaled $2,327,000 as compared with $202,000 for the same period in 2006.
          On May 6, 2004, we entered into two interest rate swap agreements (the “Swaps”) for a total notional amount of $100,000,000 to hedge changes in fair value attributable to changes in the LIBOR swap rate of $100,000,000 of fixed rate debt with a maturity date of November 15, 2013. The Swaps are treated as fair-value hedges for accounting purposes and we utilize the short-cut method to assess effectiveness. The Swaps are with highly rated counterparties in which we receive a fixed rate of 6.0% and pay a variable rate based on six-month LIBOR plus a spread. For the three months ended March 31, 2007, we generated $1,000 of savings related to our Swaps that was recorded as a reduction of interest expense. For the three months ended March 31, 2006, we incurred $15,000 of losses related to our Swaps that was recorded as an addition to interest expense.
          Depreciation and amortization increased primarily as a result of additional investments in properties owned directly by us. See the discussion of investing activities in “Liquidity and Capital Resources” above for additional details. To the extent that we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly.
          General and administrative expenses as a percentage of revenues (including revenues from discontinued operations) for the three months ended March 31, 2007, were 8.67% as compared with 7.94% for the same period in 2006. The increase from 2006 is primarily related to costs associated with our initiatives to attract and retain appropriate personnel to achieve our business objectives.

22


Table of Contents

          Loan expense represents the amortization of deferred loan costs incurred in connection with the issuance and amendments of debt. The change in loan expense is primarily due to costs associated with the issuance of $345,000,000 of senior unsecured convertible notes in November 2006 and costs related to the assumption of secured debt in connection with the Windrose merger in December 2006.
          As a result of our quarterly evaluation, we concluded that the allowance for loan losses at December 31, 2006 remained appropriate as of March 31, 2007. The provision for loan losses is related to our critical accounting estimate for the allowance for loan losses and is discussed below in “Critical Accounting Policies.”
          Other items were comprised of the following (dollars in thousands):
                                 
    Three Months Ended     Change  
    Mar. 31, 2007     Mar. 31, 2006     $     %  
Minority interests
  $ (126 )   $ 0       (126 )     n/a  
Gain (loss) on sales of properties
    977       1,553       (576 )     -37 %
Discontinued operations, net
    187       (298 )     485       n/a  
Preferred dividends
    (6,317 )     (5,333 )     (984 )     18 %
 
                       
Totals
  $ (5,279 )   $ (4,078 )   $ (1,201 )     29 %
 
                       
          Minority interests relate to certain joint venture properties acquired in connection with the Windrose merger in December 2006. There were no similar investments in the prior year period.
          One assisted living facility was held for sale as of March 31, 2007. We did not recognize an impairment loss on this asset as the fair value less estimated costs to sell exceeded our carrying value. During the three months ended March 31, 2007, we sold two assisted living facilities with carrying values of $10,560,000 for a net gain of $977,000. These properties generated $187,000 of income after deducting depreciation and interest expense from rental revenue for the three months ended March 31, 2007. All properties sold subsequent to January 1, 2005 and held for sale at March 31, 2007 generated $298,000 of losses after deducting depreciation and interest expense from rental revenue for the three months ended March 31, 2006. Please refer to Note G of our unaudited consolidated financial statements for further discussion.
          The increase in preferred stock dividends is due to an increase in average outstanding preferred shares as a result of the issuance of 2,100,000 shares of 7.5% Series G Cumulative Convertible Preferred Stock in connection with the Windrose merger in December 2006.

23


Table of Contents

Non-GAAP Financial Measures
          We believe that net income, as defined by U.S. GAAP, is the most appropriate earnings measurement. However, we consider FFO and FAD to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (“NAREIT”) created FFO as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means net income, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate, plus depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. FAD represents FFO excluding the non-cash straight-line rental adjustments.
          EBITDA stands for earnings before interest, taxes, depreciation and amortization. We believe that EBITDA, along with net income and cash flow provided from operating activities, is an important supplemental measure because it provides additional information to assess and evaluate the performance of our operations. Additionally, restrictive covenants in our long-term debt arrangements contain financial ratios based on EBITDA. We primarily utilize EBITDA to measure our interest coverage ratio, which represents EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA divided by fixed charges. Fixed charges include total interest, secured debt principal amortization and preferred dividends.
          FFO, FAD and EBITDA are financial measures that are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, FFO and FAD are utilized by the Board of Directors to evaluate management. FFO, FAD and EBITDA do not represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, FFO, FAD and EBITDA, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.
          Net operating income (“NOI”) is used to evaluate the operating performance of certain real estate properties such as medical office buildings. We define NOI as rental revenues, including tenant reimbursements, less property level operating expenses, which exclude depreciation and amortization, general and administrative expenses, impairments, interest expense and discontinued operations. We believe NOI provides investors relevant and useful information because it measures the operating performance of our medical office buildings at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our medical office buildings.

24


Table of Contents

          The table below reflects the reconciliation of FFO to net income available to common stockholders, the most directly comparable U.S. GAAP measure, for the periods presented. The provisions for depreciation and amortization include provisions for depreciation and amortization from discontinued operations. Amounts are in thousands except for per share data.
                                         
    Three Months Ended
    March 31,   June 30,   September 30,   December 31,   March 31,
    2006   2006   2006   2006   2007
     
FFO Reconciliation:
                                       
Net income (loss) available to common stockholders
  $ 19,645     $ 22,668     $ 21,480     $ 17,494     $ 23,356  
Provision for depreciation
    23,262       24,131       24,526       25,645       33,860  
Loss (gain) on sales of properties
    (1,553 )     (929 )     (108 )     1,324       (977 )
Minority interests
    0       0       0       (4 )     (32 )
     
Funds from operations
  $ 41,354     $ 45,870     $ 45,898     $ 44,459     $ 56,207  
 
                                       
Average common shares outstanding:
                                       
Basic
    58,178       61,548       62,524       64,277       73,224  
Diluted
    58,535       61,868       62,866       64,687       73,791  
 
                                       
Per share data:
                                       
Net income (loss) available to common stockholders
                                       
Basic
  $ 0.34     $ 0.37     $ 0.34     $ 0.27     $ 0.32  
Diluted
    0.34       0.37       0.34       0.27       0.32  
 
                                       
Funds from operations
                                       
Basic
  $ 0.71     $ 0.75     $ 0.73     $ 0.69     $ 0.77  
Diluted
    0.71       0.74       0.73       0.69       0.76  
          The table below reflects the reconciliation of FAD to net income available to common stockholders, the most directly comparable U.S. GAAP measure, for the periods presented. The provisions for depreciation and amortization include provisions for depreciation and amortization from discontinued operations. Amounts are in thousands except for per share data.
                                         
    Three Months Ended
    March 31,   June 30,   September 30,   December 31,   March 31,
    2006   2006   2006   2006   2007
     
FAD Reconciliation:
                                       
Net income (loss) available to common stockholders
  $ 19,645     $ 22,668     $ 21,480     $ 17,494     $ 23,356  
Provision for depreciation
    23,262       24,131       24,526       25,645       33,860  
Loss (gain) on sales of properties
    (1,553 )     (929 )     (108 )     1,324       (977 )
Gross straight-line rental income
    (2,400 )     (2,216 )     (1,904 )     (2,912 )     (4,231 )
Prepaid/straight-line rent receipts
    10,310       2,710       3,256       4,285       2,078  
Rental income related to above/(below) market leases
    0       0       0       (60 )     (460 )
Amortization of deferred loan expenses
    711       707       782       1,056       1,267  
Cap Ex, tenant improvements, lease commissions
    0       0       0       (21 )     (1,063 )
Minority interests
    0       0       0       (2 )     (5 )
     
Funds available for distribution
  $ 49,975     $ 47,071     $ 48,032     $ 46,809     $ 53,825  
 
                                       
Average common shares outstanding:
                                       
Basic
    58,178       61,548       62,524       64,277       73,224  
Diluted
    58,535       61,868       62,866       64,687       73,791  
 
                                       
Per share data:
                                       
Net income (loss) available to common stockholders
                                       
Basic
  $ 0.34     $ 0.37     $ 0.34     $ 0.27     $ 0.32  
Diluted
    0.34       0.37       0.34       0.27       0.32  
 
                                       
Funds available for distribution
                                       
Basic
  $ 0.86     $ 0.76     $ 0.77     $ 0.73     $ 0.74  
Diluted
    0.85       0.76       0.76       0.72       0.73  

25


Table of Contents

          The table below reflects the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Interest expense and the provisions for depreciation and amortization includes discontinued operations. Tax expense represents income-based taxes. Amortization represents the amortization of deferred loan expenses. Adjusted EBITDA represents EBITDA as adjusted below for items pursuant to covenant provisions of our unsecured lines of credit arrangements. Dollars are in thousands.
                                         
    Three Months Ended
    March 31,   June 30,   September 30,   December 31,   March 31,
    2006   2006   2006   2006   2007
     
EBITDA Reconciliation:
                                       
Net income
  $ 24,978     $ 28,001     $ 26,813     $ 22,958     $ 29,673  
Interest expense
    24,238       23,087       24,274       25,235       31,999  
Tax expense
    0       12       70       0       11  
Provision for depreciation
    23,262       24,131       24,526       25,645       33,860  
Amortization of deferred loan expenses
    711       707       782       1,056       1,267  
     
EBITDA
    73,189       75,938       76,465       74,894       96,810  
Stock-based compensation expense
    2,514       838       839       2,789       3,177  
Provision for loan losses
    250       250       250       250       0  
     
Adjusted EBITDA
  $ 75,953     $ 77,026     $ 77,554     $ 77,933     $ 99,987  
 
                                       
Interest Coverage Ratio:
                                       
Interest expense
  $ 24,238     $ 23,087     $ 24,274     $ 25,235     $ 31,999  
Capitalized interest
    202       908       1,384       1,976       2,327  
     
Total interest
    24,440       23,995       25,658       27,211       34,326  
EBITDA
  $ 73,189     $ 75,938     $ 76,465     $ 74,894     $ 96,810  
     
Interest coverage ratio
    2.99 x     3.16 x     2.98 x     2.75 x     2.82 x
 
                                       
Adjusted EBITDA
  $ 75,953     $ 77,026     $ 77,554     $ 77,933     $ 99,987  
     
Interest coverage ratio — adjusted
    3.11 x     3.21 x     3.02 x     2.86 x     2.91 x
 
                                       
Fixed Charge Coverage Ratio:
                                       
Total interest
  $ 24,440     $ 23,995     $ 25,658     $ 27,211     $ 34,326  
Secured debt principal amortization
    643       768       773       849       1,894  
Preferred dividends
    5,333       5,333       5,333       5,464       6,317  
     
Total fixed charges
    30,416       30,096       31,764       33,524       42,537  
EBITDA
  $ 73,189     $ 75,938     $ 76,465     $ 74,894     $ 96,810  
     
Fixed charge coverage ratio
    2.41 x     2.52 x     2.41 x     2.23 x     2.28 x
 
                                       
EBITDA — adjusted
  $ 75,953     $ 77,026     $ 77,554     $ 77,933     $ 99,987  
     
Fixed charge coverage ratio — adjusted
    2.50 x     2.56 x     2.44 x     2.32 x     2.35 x

26


Table of Contents

Critical Accounting Policies
          Our consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions. Management considers an accounting estimate or assumption critical if:
    the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and
 
    the impact of the estimates and assumptions on financial condition or operating performance is material.
          Management has discussed the development and selection of its critical accounting policies with the Audit Committee of the Board of Directors and the Audit Committee has reviewed the disclosure presented below relating to them. Management believes the current assumptions and other considerations used to estimate amounts reflected in our consolidated financial statements are appropriate and are not reasonably likely to change in the future. However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change. If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition. Please refer to our Annual Report on Form 10-K/A for the year ended December 31, 2006 for further information regarding significant accounting policies that impact us. There have been no material changes to these policies in 2007.
          The following table presents information about our critical accounting policies, as well as the material assumptions used to develop each estimate:
     
Nature of Critical   Assumptions/Approach
Accounting Estimate   Used
 
   
Allowance for Loan Losses
   
 
   
We maintain an allowance for loan losses in accordance with Statement of Financial Accounting Standards No. 114, Accounting by Creditors for Impairment of a Loan, as amended, and SEC Staff Accounting Bulletin No. 102, Selected Loan Loss Allowance Methodology and Documentation Issues. The allowance for loan losses is maintained at a level believed adequate to absorb potential losses in our loans receivable. The determination of the allowance is based on a quarterly evaluation of all outstanding loans. If this evaluation indicates that there is a greater risk of loan charge-offs, additional allowances or placement on non-accrual status may be required. A loan is impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the original loan agreement. Consistent with this definition, all loans on non-accrual are deemed impaired. To the extent circumstances improve and the risk of collectibility is diminished, we will return these loans to full accrual status.
  The determination of the allowance is based on a quarterly evaluation of all outstanding loans, including general economic conditions and estimated collectibility of loan payments and principal. We evaluate the collectibility of our loans receivable based on a combination of factors, including, but not limited to, delinquency status, historical loan charge-offs, financial strength of the borrower and guarantors and value of the underlying property.

As a result of our quarterly evaluation, we concluded that the allowance for loan losses at December 31, 2006 remained appropriate as of March 31, 2007, resulting in an allowance for loan losses of $7,406,000 relating to loans with outstanding balances of $98,399,000. Also at March 31, 2007, we had a loan with an outstanding balance of $799,000 on non-accrual status.

27


Table of Contents

     
Nature of Critical   Assumptions/Approach
Accounting Estimate   Used
 
   
Depreciation and Amortization
   
 
   
Substantially all of the properties owned by us are leased under operating leases and are recorded at cost. The cost of our real property is allocated to land, buildings, improvements and intangibles in accordance with Statement of Financial Accounting Standards No. 141, Business Combinations. The allocation of the acquisition costs of properties is based on appraisals commissioned from independent real estate appraisal firms.
  We compute depreciation and amortization on our properties using the straight-line method based on their estimated useful lives which range from 15 to 40 years for buildings and five to 15 years for improvements. Lives for intangibles are based on the remaining term of the underlying leases.

For the three months ended March 31, 2007, we recorded $27,155,000, $4,128,000 and $2,577,000 as provisions for depreciation and amortization relating to buildings, improvements and intangibles, respectively, including amounts reclassified as discontinued operations. The average useful life of our buildings, improvements and intangibles was 32.3 years, 11.7 years and 5.0 years, respectively, for the three months ended March 31, 2007.
 
   
Impairment of Long-Lived Assets
   
 
   
We review our long-lived assets for potential impairment in accordance with Statement of Financial Accounting Standards No. 144, Accounting for the Impairment and Disposal of Long-Lived Assets. An impairment charge must be recognized when the carrying value of a long-lived asset is not recoverable. The carrying value is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If it is determined that a permanent impairment of a long-lived asset has occurred, the carrying value of the asset is reduced to its fair value and an impairment charge is recognized for the difference between the carrying value and the fair value.
  The net book value of long-lived assets is reviewed quarterly on a property by property basis to determine if there are indicators of impairment. These indicators may include anticipated operating losses at the property level, the tenant’s inability to make rent payments, a decision to dispose of an asset before the end of its estimated useful life and changes in the market that may permanently reduce the value of the property. If indicators of impairment exist, then the undiscounted future cash flows from the most likely use of the property are compared to the current net book value. This analysis requires us to determine if indicators of impairment exist and to estimate the most likely stream of cash flows to be generated from the property during the period the property is expected to be held.

We did not record any impairment charges for the three months ended March 31, 2007.
 
   
Fair Value of Derivative Instruments
   
 
   
The valuation of derivative instruments is accounted for in accordance with Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activities (“SFAS133”), as amended by Statement of Financial Accounting Standards No. 138, Accounting for Certain Derivative Instruments and Certain Hedging Activities. SFAS133, as amended, requires companies to record derivatives at fair market value on the balance sheet as assets or liabilities.
  The valuation of derivative instruments requires us to make estimates and judgments that affect the fair value of the instruments. Fair values for our derivatives are estimated by a third party consultant, which utilizes pricing models that consider forward yield curves and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates which may change in the future. At March 31, 2007, we participated in two interest rate swap agreements related to our long-term debt. At March 31, 2007, the swaps were reported at their fair value as a $1,230,000 other asset. For the three months ended March 31, 2007, we generated $1,000 of savings related to our swaps that was recorded as a reduction to interest expense.

28


Table of Contents

     
Nature of Critical   Assumptions/Approach
Accounting Estimate   Used
 
   
Revenue Recognition
   
 
   
Revenue is recorded in accordance with Statement of Financial Accounting Standards No. 13, Accounting for Leases, and SEC Staff Accounting Bulletin No. 104, Revenue Recognition in Financial Statements, as amended (“SAB104”). SAB104 requires that revenue be recognized after four basic criteria are met. These four criteria include persuasive evidence of an arrangement, the rendering of service, fixed and determinable income and reasonably assured collectibility. If the collectibility of revenue is determined incorrectly, the amount and timing of our reported revenue could be significantly affected. Interest income on loans is recognized as earned based upon the principal amount outstanding subject to an evaluation of collectibility risk. Substantially all of our operating leases contain either fixed or contingent escalating rent structure. Leases with fixed annual rental escalators are generally recognized on a straight- line basis over the initial lease period, subject to a collectibility assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period.
  We evaluate the collectibility of our revenues and related receivables on an on-going basis. We evaluate collectibility based on assumptions and other considerations including, but not limited to, the certainty of payment, payment history, the financial strength of the investment’s underlying operations as measured by cash flows and payment coverages, the value of the underlying collateral and guaranties and current economic conditions.

If our evaluation indicates that collectibility is not reasonably assured, we may place an investment on non-accrual or reserve against all or a portion of current income as an offset to revenue.

For the three months ended March 31, 2007, we recognized $5,149,000 of interest income and $106,168,000 of rental income, including discontinued operations. Cash receipts on leases with deferred revenue provisions were $2,078,000 as compared to gross straight-line rental income recognized of $4,231,000 for the three months ended March 31, 2007. At March 31, 2007, our straight-line receivable balance was $55,374,000, net of reserves totaling $4,619,000. Also at March 31, 2007, we had a loan with an outstanding balance of $799,000 on non-accrual status.
Forward-Looking Statements and Risk Factors
          This Quarterly Report on Form 10-Q may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements concern and are based upon, among other things, the possible expansion of the company’s portfolio; the sale of properties; the performance of its operators/tenants and properties; its occupancy rates; its ability to acquire or develop properties; its ability to manage properties; its ability to enter into agreements with new viable tenants for vacant space or for properties that the company takes back from financially troubled tenants, if any; its ability to make distributions; its policies and plans regarding investments, financings and other matters; its tax status as a real estate investment trust; its ability to appropriately balance the use of debt and equity; its ability to access capital markets or other sources of funds; its critical accounting policies; and its ability to meet its earnings guidance. When the company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The company’s expected results may not be achieved, and actual results may differ materially from expectations. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including prevailing interest rates; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies and operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and senior housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; the company’s ability to transition or sell facilities with a profitable result; the failure of closings to occur as and when anticipated; acts of God affecting the company’s properties; the company’s ability to timely reinvest sale proceeds at similar rates to assets sold; the company’s ability to re-lease space at similar rates as vacancies occur; operator/tenant bankruptcies or insolvencies; government regulations affecting Medicare and Medicaid reimbursement rates; liability or contract claims by or against operators and tenants; unanticipated difficulties and/or expenditures relating to future acquisitions and the integration of multi-property acquisitions; environmental laws affecting the company’s properties; changes in rules or practices governing the company’s financial reporting; and legal and operational matters, including real estate investment trust qualification and key management personnel recruitment and retention. Other important factors are identified in our Annual Report on Form 10-K/A for the year ended December 31, 2006, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Finally, we assume no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.

29


Table of Contents

Item 3. Quantitative and Qualitative Disclosures about Market Risk
          We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates.
          We historically borrow on our unsecured lines of credit arrangements to acquire, construct or make loans relating to health care and senior housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under the unsecured lines of credit arrangements.
          A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. At March 31, 2007, we had $1,539,830,000 of outstanding principal balances related to our senior unsecured notes. A 1% increase in interest rates would result in a decrease in fair value of our senior unsecured notes by approximately $70,366,000 at March 31, 2007. At March 31, 2006, we had $1,194,830,000 of outstanding principal balances related to our senior unsecured notes. A 1% increase in interest rates would result in a decrease in fair value of our senior unsecured notes by approximately $35,175,000 at March 31, 2006. At March 31, 2007, we had $362,027,000 of outstanding principal balances related to our fixed rate secured debt. A 1% increase in interest rates would result in a decrease in fair value of our fixed rate secured debt by approximately $16,584,000 at March 31, 2007. At March 31, 2006, we had $131,946,000 of outstanding principal balances related to our fixed rate secured debt. A 1% increase in interest rates would result in a decrease in fair value of our fixed rate secured debt by approximately $5,933,000 at March 31, 2006. At March 31, 2007, we had $51,000,000 of outstanding principal balances related to our liability to a subsidiary trust issuing preferred securities. A 1% increase in interest rates would result in a decrease in fair value of this liability by approximately $1,794,000 at March 31, 2007. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt, or equity or repaid by the sale of assets.
          On May 6, 2004, we entered into two interest rate swap agreements (the “Swaps”) for a total notional amount of $100,000,000 to hedge changes in fair value attributable to changes in the LIBOR swap rate of $100,000,000 of fixed rate debt with a maturity date of November 15, 2013. The Swaps are treated as fair-value hedges for accounting purposes and we utilize the short-cut method in accordance with Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended. The Swaps are with highly rated counterparties in which we receive a fixed rate of 6.0% and pay a variable rate based on six-month LIBOR plus a spread. At March 31, 2007, the Swaps were reported at their fair value as a $1,230,000 other asset ($651,000 other liability at March 31, 2006). A 1% increase in interest rates would result in a decrease in fair value of our Swaps by approximately $5,427,000 at March 31, 2007 ($6,328,000 at March 31, 2006). Assuming no changes in the notional amount of $100,000,000 of our Swaps, a 1% increase in interest rates would result in increased annual interest expense of $1,000,000.
          Our variable rate debt, including our unsecured lines of credit arrangements, is reflected at fair value. At March 31, 2007, we had $381,000,000 outstanding related to our variable rate debt and assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $3,810,000. At March 31, 2006, we had $201,000,000 outstanding related to our variable rate debt and assuming no changes in outstanding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $2,010,000.
          We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.

30


Table of Contents

Item 4. Controls and Procedures
          Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the Securities and Exchange Commission (“SEC”) under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. During the quarter ended March 31, 2007, we implemented JD Edwards EnterpriseOne, a new enterprise management reporting system, which among other functions, is used to process and accumulate financial data principally supporting rent and interest income, accounts receivable, fixed assets, accounts payable and general ledger transactions. The new system replaces several separate software systems and consolidates the aforementioned functions into a more efficient system which is easier to maintain. We believe this system consolidation represents a material change to our internal control over financial reporting. No other changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1A. Risk Factors
          Except as provided in “Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – Forward Looking Statements and Risk Factors,” there have been no material changes from the risk factors identified under the heading “Risk Factors” in our Annual Report on Form 10-K/A for the year ended December 31, 2006.
Item 5. Other Information
Entry into a Material Definitive Agreement
          On May 7, 2007, the company and certain of its subsidiaries entered into a new $40,000,000 unsecured line of credit arrangement with Fifth Third Bank, which expires on May 31, 2008. Borrowings under this line of credit are subject to interest at either the lender’s prime rate of interest or 0.8% over LIBOR interest rate, at our option. Principal is due upon expiration of the agreement. The agreement includes customary representations and warranties by the company and certain of its subsidiaries and the borrowings under the agreement are subject to acceleration upon the occurrence of certain events of default.
          The foregoing description does not purport to be a complete statement of the parties’ rights and obligations under this line of credit. The above description is qualified in its entirety by reference to the Credit Agreement by and among the company and certain of its subsidiaries and Fifth Third Bank, dated as of May 31, 2007, which is filed as Exhibit 10.3 to this Quarterly Report on Form 10-Q.
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
          See the disclosure above regarding the new $40,000,000 unsecured line of credit.
Item 6. Exhibits
  10.1   Third Amended and Restated Employment Agreement, dated January 22, 2007, by and between Health Care REIT, Inc. and George L. Chapman (filed with the SEC as Exhibit 10.1 to Health Care REIT, Inc.’s Form 8-K filed January 25, 2007, and incorporated herein by reference thereto).
 
  10.2   Restricted Stock Agreement, dated January 22, 2007, by and between Health Care REIT, Inc. and Raymond W. Braun (filed with the SEC as Exhibit 10.2 to Health Care REIT, Inc.’s Form 8-K filed January 25, 2007, and incorporated herein by reference thereto).
 
  10.3   Credit Agreement by and among Health Care REIT, Inc. and certain of its subsidiaries and Fifth Third Bank, dated as of May 31, 2007.
 
  10.4   Stock Option Agreement, dated December 20, 2006, between Health Care REIT, Inc. and Daniel R. Loftus.
 
  31.1   Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.
 
  31.2   Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.
 
  32.1   Certification pursuant to 18 U.S.C. Section 1350 by Chief Executive Officer.
 
  32.2   Certification pursuant to 18 U.S.C. Section 1350 by Chief Financial Officer.

31


Table of Contents

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HEALTH CARE REIT, INC.
                     
Date:
  May 10, 2007       By:   /s/ George L. Chapman    
 
                   
            George L. Chapman,
Chairman and Chief Executive Officer
(Principal Executive Officer)
   
 
                   
Date:
  May 10, 2007       By:   /s/ Scott A. Estes    
 
                   
            Scott A. Estes,
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
   
 
                   
Date:
  May 10, 2007       By:   /s/ Paul D. Nungester, Jr.    
 
                   
            Paul D. Nungester, Jr.,
Vice President and Controller
(Principal Accounting Officer)
   

32

EX-10.3 2 l26083aexv10w3.htm EX-10.3 EX-10.3
 

EXHIBIT 10.3
CREDIT AGREEMENT
     This Credit Agreement (the “Agreement”) is entered into as of the 31st day of May 2007, by and between HEALTH CARE REIT, INC., a Delaware corporation (“HCN”), and each of the entities listed on Schedule I attached hereto (HCN and such other entities may hereinafter be referred to collectively as “Borrowers”), and FIFTH THIRD BANK, an Ohio banking corporation (“Bank”).
Section 1. Definitions.
     All financial terms used in the Agreement but not defined in the Loan Documents (as defined below) have the meanings given to them by generally accepted accounting principles (“GAAP”). All other undefined terms have the meanings given to them in the Ohio Uniform Commercial Code.
Section 2. Loan(s).
     2.01 Revolving Credit Loan.
              (a) Subject to the terms and conditions hereof, Bank hereby extends to Borrowers a line of credit facility (the “Facility” or the “Loan”) under which Bank may make loans (the “Revolving Loans”) to Borrowers at Borrowers’ requests from time to time during the term of this Agreement. Bank will have discretion at all times as to whether or not to make any Revolving Loan if there is any Event of Default (as defined below). Borrower may borrow, prepay, and reborrow under the Facility, provided that the principal amount of all Revolving Loans outstanding at any one time under the Facility will not exceed the foregoing limits or those limits specified in the Revolving Note. If the amount of the Revolving Loans outstanding at any time under the Facility exceeds the limits set forth above or in the Revolving Note, Borrower will immediately pay the amount of such excess to Bank in certified funds. Bank has agreed to make this Loan upon the terms and subject to the conditions of this Agreement and all documents executed pursuant to or in connection with this Agreement (all such documents and this Agreement will be called “Loan Documents”).
              (b) Borrowers may request a Revolving Loan by written or telephone notice to Bank. Bank will make a Revolving Loan by crediting the amount thereof to Borrowers’ account at Bank. Loan proceeds will be used for working capital and general corporate purposes, including acquisitions and the repayment/refinancing of other indebtedness.
              (c) On the date hereof, Borrowers will duly issue and deliver to Bank a revolving note (the “Revolving Note” or “Note”) in the principal amount of Forty Million and 00/100 Dollars ($40,000,000.00) bearing interest as specified in Section 2.02.
              (d) The term of the Facility will expire on May 30, 2008 and the Revolving Note will become payable in full on that date.
     2.02 Interest on Revolving Loans. The principal amounts outstanding hereunder shall bear interest commencing on the date of the first advance hereunder at the rate or rates per annum set forth below which shall be designated by Borrowers as more fully set forth herein. At any time, from time to time, during the term of the Note, so long as no Event of Default exists and so long as such Borrowings (as defined in the Note) are not then subject to an Interest Rate Election (as defined below), Borrowers may notify Bank that they wish to exercise their right to adjust the rate of interest accruing on some or all amounts of principal outstanding under the Note (in a minimum amount of $500,000) to one of the rates set forth below, however, once the rate of interest accruing against any amounts outstanding hereunder is

1


 

adjusted to one of the following interest rates during an interest period, Borrowers may not elect to adjust such interest rate to a different interest rate until the expiration of such interest period:
              (a) LIBOR Rate. Upon telephonic notice by a Borrower to Bank, Borrower may elect to have all or any portion of the Borrowings in a minimum amount of $500,000 per election bear interest at the per annum rate equal to eighty (80) basis points in excess of the LIBOR Rate (as defined below) (a “LIBOR Rate Election”). Such notice shall inform Bank of the amount of Borrowings to be subject to the LIBOR Rate Election, the LIBOR Interest Period (as defined below) and the Effective Date (as defined below) of the LIBOR Interest Period.
                            Borrowers’ right to make a LIBOR Rate Election shall be terminated automatically if Bank, by telephonic notice, shall notify Borrowers that LIBOR deposits with a maturity corresponding to the maturity of the LIBOR Interest Period, in an amount equal to the Borrowings to be subject to the LIBOR Rate Election are not readily available in the London Inter-Bank Offered Rate Market, or that, by reason of circumstances affecting such market, adequate and reasonable methods do not exist for ascertaining the interest rate applicable to such deposits for the proposed LIBOR Interest Period.
                            In addition, notwithstanding anything herein contained to the contrary, if, prior to or during any period with respect to which a LIBOR Rate is in effect, any change in any law, regulation or official directive, or in the interpretation thereof, by any governmental body charged with the administration thereof, shall make it unlawful for the Bank to fund or maintain its funding in Eurodollars of any portion of the Borrowings subject to the LIBOR Rate or otherwise to give effect to Bank’s obligations as contemplated hereby, (i) Bank may by written notice to Borrowers, declare Bank’s obligations in respect of the LIBOR Rate to be terminated forthwith, and (ii) the LIBOR Rate with respect to Bank shall forthwith cease to be in effect, and interest shall from and after such date be calculated at the Prime Rate, unless Borrowers shall thereafter make one or more other Interest Rate Elections.
              (b) Prime Rate. Upon telephonic notice by a Borrower to Bank prior to or on the Effective Date, Borrowers may elect to have all or part of the Borrowings (provided such Borrowings are not then subject to an Interest Rate Election) bear interest at the per annum rate equal to the Prime Rate (as defined below) (a “Prime Rate Election”). Such telephonic notice shall inform Bank of the amount of the Borrowings to be subject to the Prime Rate Election, the Prime Rate Interest Period (as defined below) and the Effective Date for the Prime Rate Interest Period.
                            If at any time during the term hereof, (i) the outstanding principal hereunder is less than $500,000, or (ii) Borrowers fail to designate one of the interest rates set forth above or at any time after Borrowers have elected to adjust the interest rate accruing on any principal outstanding hereunder to a rate other than the fixed rate set forth above, at the expiration of any interest period, if Borrowers have not made another Interest Rate Election hereunder, then in either such event, such outstanding amounts of principal will accrue interest at a rate of interest equal to the Prime Rate.
              (c) Minimum Borrowing Amounts and Prepayment. Each Borrowing subject to an Interest Rate Election that is advanced, continued or converted shall be in an amount equal to $500,000 or such greater amount which is an integral multiple of $100,000. The Borrowers may prepay without premium or penalty and in whole or in part any Borrowing subject to a LIBOR Rate Election at any time upon three (3) business days prior notice by the Borrowers to the Bank or, in the case of a Borrowing subject to a Prime Rate Election, notice delivered by the Borrowers to the Bank no later than 2:00 p.m. (Toledo time) on the date of prepayment, such prepayment to be made by the payment of the principal amount to be prepaid and, in the case of any Borrowing subject to a LIBOR Rate Election, accrued interest thereon to the date fixed for prepayment; provided, however, the Borrowers may not partially

2


 

repay a Borrowing (i) if such Borrowing is subject to a Prime Rate Election, in a principal amount less than $500,000, (ii) if such Borrowing is subject to a LIBOR Rate Election, in a principal amount not less than $500,000 or any amount in excess thereof that is not an integral multiple of $100,000, and (iii) in each case, unless it is in an amount such that the minimum amount required for a Borrowing pursuant to Section 2.02 remains outstanding. Any amount of Loans paid or prepaid before May 31, 2008 may, subject to the terms and conditions of this Agreement, be borrowed, repaid and borrowed again.
              (d) Defined Terms. As used herein, the following terms will have the meanings set forth below:
                            (i) “Effective Date” means the date on which a LIBOR Rate Election or Prime Rate Election will begin.
                            (ii) “Interest Rate Election” means a LIBOR Rate Election, or a Prime Rate Election, or any one or more of the foregoing.
                            (iii) “LIBOR Interest Period” means, with respect to a Borrowing elected to accrue interest at the LIBOR Rate, a period of 30, 60 or 90 days commencing on a business day selected by the Borrowers pursuant to this Agreement. Such LIBOR Interest Period shall end on the day in the succeeding calendar month which corresponds numerically to the beginning day of such LIBOR Interest Period, provided, however, that if there is no such numerically corresponding day in such succeeding month, such LIBOR Interest Period shall end on the last business day of such succeeding month. If a LIBOR Interest Period would otherwise end on a day which is not a business day, such LIBOR Interest period shall end on the next succeeding business day, provided, however, that if said next succeeding business day falls in a new month, such LIBOR Interest Period shall end on the immediately preceding business day.
                            (iv) “LIBOR Rate” means the rate (adjusted for reserves if Bank is required to maintain reserves with respect to relevant advances) being asked on an amount of Eurodollar deposits equal to the amount of Borrowings subject to a LIBOR Rate on the first day of a LIBOR Interest Period and which has a maturity corresponding to the maturity of the LIBOR Interest Period, as reported by the TELERATE rate reporting system (or any successor) as determined by the Bank by noon on the Effective Date of the LIBOR Interest Period. Each determination by Bank of the LIBOR Rate shall be conclusive in the absence of manifest error.
                            (v) “Prime Rate” means the rate established by Bank from time to time as its Prime Rate based upon its considerations of various factors and is not necessarily Bank’s most favored interest rate.
                            (vi) “Prime Rate Interest Period” means any period with respect to which the Borrowers make a Prime Rate Election or the Borrowers have made an Interest Rate Election which has expired and the Borrowers have failed to make an alternate Interest Rate Election. If a Prime Rate Interest Period would otherwise end on a day which is not a business day, such Prime Rate Interest Period shall end on the next succeeding business day.
     2.03 Statements. After the end of each quarter, Bank will render to Borrowers a statement on each of Borrowers’ loan accounts with Bank hereunder, which statement will be considered correct and will be conclusively binding upon Borrowers unless Borrowers notify Bank in writing of any discrepancy within thirty (30) days from the date of such statement.

3


 

Section 3. Representations And Warranties.
     3.01 Incorporation by Reference. The provisions of the following sections (including the contents of the related schedules and exhibits) of the Existing or Replacement Agreement (as defined below) are incorporated herein by reference in their entirety as in effect on the date hereof, or as any replacement agreement may be in effect after the date hereof, after giving effect to any terminations, further amendments and/or waivers after the date hereof, or the payment in full of the amounts subject thereto, with (a) the defined terms used therein and the definitions of such terms being construed in accordance with this Agreement, and (b) section references therein being deemed to be references to sections of the Existing or Replacement Agreement as incorporated by reference herein: Section 3.1 through and including Section 3.17. The Borrowers hereby represent and warrant to the Bank the sections of the Existing or Replacement Agreement incorporated herein by this Section 3.01 for the benefit of the Bank as if such sections were set forth directly in this Agreement. With regard to Section 3.12 incorporated herein, the reference to “Section 2.8 hereof” shall be deemed to be a reference to Section 2.01(b) of this Agreement.
     3.02 Existing or Replacement Agreement. “Existing or Replacement Agreement” means that certain Third Amended and Restated Loan Agreement by and among HCN, its subsidiaries party thereto, the banks signatory thereto, KeyBank National Association, as Administrative Agent, Deutsche Bank Securities Inc., as Syndication Agent, and UBS Securities LLC, Bank of America, N.A. and JPMorgan Chase Bank, N.A. as Documentation Agents, dated July 26, 2006, as amended by Amendment No. 1 to Third Amended and Restated Loan Agreement, dated September 20, 2006, as such agreement is in effect on the date hereof or may be amended or supplemented hereafter, or as any replacement agreement may be in effect after the date hereof, after giving effect to any terminations, further amendments or supplements and/or waivers after the date hereof or the payment in full of the amounts subject thereto. HCN agrees to promptly provide to Bank a copy of any and all such amendments, supplements and replacement agreements.
Section 4. Covenants.
     4.01 Incorporation by Reference. The provisions of the following articles and sections (including the contents of the related schedules and exhibits) of the Existing or Replacement Agreement are incorporated herein by reference in their entirety as in effect on the date hereof, after giving effect to any terminations, amendments, replacements or waivers thereof after the date hereof, or the payment in full of the amounts subject thereto, with (a) the defined terms used therein and the definitions of such terms being construed in accordance with this Agreement, and (b) section references therein being deemed to be references to sections of the Existing or Replacement Agreement as incorporated by reference herein: Article 5 (including Section 5.1 through and including Section 5.13), Article 6 (including Section 6.1 through and including Section 6.13) and Article 7 (including Section 7.1 through and including Section 7.16). The Borrowers hereby covenant and agree to observe, perform and comply with the articles and sections of the Existing or Replacement Agreement incorporated herein by this Section 4.01 for the benefit of the Bank as if such articles and sections were set forth directly in this Agreement.
Section 5. Events of Default and Remedies.
     5.01 Events of Default. Any one or more of the events set forth in Article 8 of the Existing or Replacement Agreement shall constitute an “Event of Default” hereunder.
     5.02 Remedies. Except as otherwise provided in Article 8 of the Existing or Replacement Agreement, if any Event of Default will occur, Bank may by written notice to the Borrowers cease advancing money hereunder, and/or declare all obligations to be due and payable forthwith, whereupon they will forthwith become due and payable without further presentment, demand, protest, or notice of any kind, all of which are hereby expressly waived by Borrower; provided, however, that no such written notice to the

4


 

Borrowers shall be required when any Event of Default described in Section 8.6 of the Existing or Replacement Agreement has occurred and is continuing.
              5.03 Setoff. If any Event of Default will occur, Bank is authorized, without advance notice but otherwise with notice to Borrowers, to offset and apply to all or any part of the Note all moneys, credits and other property of any nature whatsoever of Borrowers now or at any time hereafter in the possession of, in transit to or from, under the control or custody of, or on deposit with Bank, including but not limited to certificates of deposit.
              5.04 Default Rate. While any Event of Default exists, the Borrowers shall pay interest (after as well as before entry of judgment thereon to the extent permitted by law) on the principal amount of all Loans owing by it at a rate per annum equal to:
                            (i) for any Borrowing subject to a Prime Rate Election, the sum of 2.0% per annum plus the Prime Rate; and
                            (ii) for any Borrowing subject to a LIBOR Rate Election, the sum of 4.0% per annum plus the LIBOR Rate in effect thereon at the time of such default until the end of the interest period applicable thereto and, thereafter, at a rate per annum equal to the sum of 2.0% plus the Prime Rate;
provided, however, that in the absence of acceleration, any adjustments pursuant to this section shall be made at the election of the Bank, with written notice to the Borrowers. While any Event of Default exists or after acceleration, interest shall be paid on demand of the Bank. This provision does not constitute a waiver of any Event of Default or an agreement by Bank to permit any late payments whatsoever.
     5.05 No Remedy Exclusive. No remedy set forth herein is exclusive of any other available remedy or remedies, but each is cumulative and in addition to every other remedy available under this Agreement, the Loan Documents or as may be now or hereafter existing at law, in equity or by statute.
     5.06 Effect of Termination. The termination of this Agreement will not affect any rights of either party or any obligation of either party to the other, arising prior to the effective date of such termination, and the provisions hereof shall continue to be fully operative until all transactions entered into, rights created or obligations incurred prior to such termination have been fully disposed of, concluded or liquidated.
Section 6. Conditions Precedent.
     6.01 Conditions to Loan. Bank will have no obligation to make or advance any Loan until Borrowers have delivered to Bank at or before the closing date, in form and substance satisfactory to Bank:
              (a) An executed Revolving Note of even date herewith.
              (b) A corporate resolution of HCN.
              (c) Certification of signing authority for Borrowers.

5


 

              (d) An executed copy of this Agreement.
              (e) Such additional information and materials as Bank may reasonably request.
     6.02 Conditions to Each Loan. On the date of any Loan under the Revolving Note, the following statements will be true:
              (a) All of the representations and warranties contained herein and in the Loan Documents will be correct in all material respects as though made on such date.
              (b) No event will have occurred and be continuing, or would result from such Loan, which constitutes an Event of Default, or would constitute an Event of Default but for the requirement that notice be given or lapse of time or both.
              (c) The aggregate unpaid principal amount of the Revolving Loans after giving effect to such Revolving Loans will not violate the lending limits set forth in Section 2.01 of this Agreement.
              The acceptance by Borrowers of the proceeds of each Loan will be deemed to constitute a representation and warranty by Borrowers that the conditions in Section 6.02 of this Agreement, other than those that have been waived in writing by Bank, have been satisfied.
Section 7. Miscellaneous Provisions.
     7.01 Miscellaneous. This Agreement, the exhibits and the other Loan Documents are the complete agreement of the parties hereto and supersede all previous understandings relating to the subject matter hereof. This Agreement may be amended only in writing signed by the party against whom enforcement of this amendment is sought. This Agreement may be executed in counterparts. If any part of this Agreement is held invalid, the remainder of this Agreement will not be affected thereby. This Agreement is and is intended to be a continuing agreement and will remain in full force and effect until the Loans are finally and irrevocably paid in full.
     7.02 Waiver by Borrowers. Borrowers waive notice of non-payment, demand, presentment, protest or notice of protest, and all other notices (except those notices specifically provided for in this Agreement or other Loan Documents); consents to any renewals or extensions of time of payment thereof; and generally waives any and all suretyship defenses and defenses in the nature thereof.
     7.03 Binding Effect. This Agreement will be binding upon and inure to the benefit of the respective legal representatives, successors and assigns of the parties hereto; however, Borrowers may not assign any of its rights or delegate any of its obligations hereunder. Bank (and any subsequent assignee) may transfer and assign this Agreement or may assign partial interests or participation in the Loans to other persons. Bank may disclose to all prospective and actual assignees and participants all financial, business and other information about Borrowers which Bank may possess at any time.
     7.04 Survival. All representations, warranties, covenants and agreements made by Borrowers herein and in the Loan Documents will survive the execution and delivery of this Agreement, the Loan Documents and the issuance of the Note.
     7.05 Delay or Omission. No delay or omission on the part of Bank in exercising any right, remedy or power arising from any Event of Default will impair any such right, remedy or power or be considered a waiver of any right, remedy or power or any Event of Default; and the action or omission to act

6


 

by Bank upon the occurrence of any Event of Default will not impair any right, remedy or power arising as a result thereof or affect any subsequent Event of Default of the same or different nature.
     7.06 Notices. Any notices under or pursuant to this Agreement will be deemed duly sent when delivered in hand or when mailed by registered or certified mail, return receipt requested, addressed as follows:
     
To Borrowers:
  Health Care REIT, Inc.
One SeaGate, Suite 1500
Toledo, Ohio 43604
Attention: Michael A. Crabtree, Vice President and Treasurer
 
   
With a copy to:
  Mary Ellen Pisanelli
Shumaker, Loop & Kendrick, LLP
1000 Jackson Street
Toledo, Ohio 43624
 
   
To Bank:
  Fifth Third Bank
606 Madison Avenue
Toledo, Ohio 43604
Attention: Jeffrey A. Thieman, Vice President
     Either party may change such address by sending notice of the change to the other party.
     7.07 No Partnership. Nothing contained herein or in any of the Loan Documents is intended to create or will be construed to create any relationship between Bank and the Borrowers other than as expressly set forth herein or therein and will not create any joint venture, partnership or other relationship.
     7.08 Indemnification. If after receipt of any payment of all or part of the Note, Bank is for any reason compelled to surrender such payment to any person or entity, because such payment is determined to be void or voidable as a preference, impermissible setoff, or diversion of trust funds, or for any other reason, this Agreement will continue in full force and effect and Borrowers will be liable to, and will indemnify, save and hold Bank, its officers, directors, attorneys, and employees harmless of and from the amount of such payment surrendered. The provisions of this section will be and remain effective notwithstanding any contrary action which may have been taken by Bank in reliance on such payment, and any such contrary action so taken will be without prejudice to Bank’s rights under this Agreement and will be deemed to have been conditioned upon such payment becoming final, indefeasible and irrevocable. In addition, Borrowers will indemnify, defend, save and hold Bank, its officers, directors, attorneys, and employees harmless of, from and against all claims, demands, liabilities, judgments, losses, damages, costs and expenses, joint or several (including all accounting fees and attorneys’ fees reasonably incurred), that Bank or any such indemnified party may incur arising out of this Agreement, any of the Loan Documents or any act taken by Bank hereunder except for the willful misconduct or gross negligence of such indemnified party. The provisions of this section will survive the termination of this Agreement.
     7.09 Governing Law; Jurisdiction. This Agreement, the Note and the other Loan Documents will be governed by the domestic laws of the State of Ohio. Borrowers agree that the state and federal courts in Lucas County, Ohio, or any other court in a jurisdiction in which the Borrowers do business and in which Bank initiates proceedings have exclusive jurisdiction over all matters arising out of this Agreement, and that service of process in any such proceeding will be effective if mailed to Borrowers at its address described in Section 7.06 of this Agreement. BANK AND BORROWERS HEREBY WAIVE THE RIGHT TO TRIAL

7


 

BY JURY OF ANY MATTERS ARISING OUT OF THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED THEREBY.
IN WITNESS WHEREOF, Borrowers and Bank have executed this Agreement by their duly authorized officers as of the date first above written.
HEALTH CARE REIT, INC.
HCRI PENNSYLVANIA PROPERTIES, INC.
HCRI TEXAS PROPERTIES, INC.
HCRI TEXAS PROPERTIES, LTD.
     By Health Care REIT, Inc.,
     Its General Partner
HCRI NEVADA PROPERTIES, INC.
HCRI LOUISIANA PROPERTIES, L.P.
     By HCRI Southern Investments I, Inc.,
     Its General Partner
HEALTH CARE REIT INTERNATIONAL, INC.
HCN ATLANTIC GP, INC.
HCN ATLANTIC LP, INC.
HCN BCC HOLDINGS, INC.
HCRI INDIANA PROPERTIES, INC.
HCRI INDIANA PROPERTIES, LLC
     By Health Care REIT, Inc.,
     Its Member
HCRI LIMITED HOLDINGS, INC.
HCRI MASSACHUSETTS PROPERTIES, INC.
HCRI MASSACHUSETTS PROPERTIES TRUST
     By HCRI Massachusetts Properties, Inc.
     Its Trustee
HCRI HOLDINGS TRUST
     By HCRI Massachusetts Properties, Inc.
     Its Trustee
HCRI NORTH CAROLINA PROPERTIES, LLC
     By HCRI North Carolina Properties I, Inc.
     Its Member
HCRI SOUTHERN INVESTMENTS I, INC.
HCRI TENNESSEE PROPERTIES, INC.
PENNSYLVANIA BCC PROPERTIES, INC.
HCRI KENTUCKY PROPERTIES, LLC
     By Health Care REIT, Inc.
     Its Member
HCRI MASSACHUSETTS PROPERTIES TRUST II
     By HCRI Massachusetts Properties, Inc.
     Its Trustee
HCRI MARYLAND PROPERTIES, LLC
     By Health Care REIT, Inc.
     Its Member
HCRI NORTH CAROLINA PROPERTIES I, INC.

     [Borrowers continued on following page]

8


 

HCRI NORTH CAROLINA PROPERTIES III, LIMITED PARTNERSHIP
     By HCRI North Carolina Properties II, Inc.
     Its General Partner
HCRI NORTH CAROLINA PROPERTIES II, INC.
HCRI WISCONSIN PROPERTIES, LLC
     By Health Care REIT, Inc.
     Its Member
HCRI MISSISSIPPI PROPERTIES, INC.
HCRI ILLINOIS PROPERTIES, LLC
     By Health Care REIT, Inc.
     Its Member
HCRI MISSOURI PROPERTIES, LLC
     By Health Care REIT, Inc.
     Its Member
HCRI SURGICAL PROPERTIES, LLC
     By Health Care REIT, Inc.
     Its Member
HCRI TUCSON PROPERTIES, INC.
HCRI INVESTMENTS, INC.
HCRI CHICAGO PROPERTIES, INC.
HCRI GENERAL PROPERTIES, INC.
HCRI KANSAS PROPERTIES, LLC
     By Health Care REIT, Inc.
     Its Member
HCRI TENNESSEE PROPERTIES, LLC
     By HCRI Tennessee Properties, Inc.
     Its Member
HH FLORIDA, LLC
     By Limited Holdings, Inc.
     Its Member
HCRI NEW HAMPSHIRE PROPERTIES, LLC
     By Health Care REIT, Inc.
     Its Member
HCRI PROVIDER PROPERTIES, LLC
     By Health Care REIT, Inc.
     Its Member
1920 CLEVELAND ROAD WEST, LLC
     By Health Care REIT, Inc., as the Member of
     HCRI Provider Properties, LLC
     Its Member
721 HICKORY STREET, LLC
     By Health Care REIT, Inc., as the Member of
     HCRI Provider Properties, LLC
     Its Member
111 LAZELLE ROAD EAST, LLC
     By Health Care REIT, Inc., as the Member of
     HCRI Provider Properties, LLC
     Its Member
5166 SPANSON DRIVE SE, LLC
     By Health Care REIT, Inc., as the Member of
     HCRI Provider Properties, LLC
     Its Member

     [Borrowers continued on following page]

9


 

1425 YORKLAND ROAD, LLC
     By Health Care REIT, Inc., as the Member of
     HCRI Provider Properties, LLC
     Its Member
222 EAST BEECH STREET — JEFFERSON, L.L.C.
     By Health Care REIT, Inc., as the Member of
     HCRI Provider Properties, LLC
     Its Member
HCRI SENIOR HOUSING PROPERTIES, INC.
209 MERRIMAN ROAD, L.L.C.
     By Health Care REIT, Inc., as the Member of
     HCRI Provider Properties, LLC
     Its Member
HCRI FINANCING, INC.
         
 
           
 
  By   /s/ Michael A. Crabtree
 
       
 
      Name: Michael A. Crabtree
 
      Title: Vice President and Treasurer
    Michael A. Crabtree, as Vice President and Treasurer of all of the aforementioned entities, has executed this Agreement and intending that all entities above named are bound and are to be bound by the one signature as if he had executed this Agreement separately for each of the above named entities.
         
    FIFTH THIRD BANK,
    an Ohio banking corporation

 
  By   /s/ Jeffrey A. Thieman
 
       
 
      Name: Jeffrey A. Thieman
 
      Title: Vice President

10


 

Schedule I
List Of Borrowers
     
Name of Borrower
  State of Organization
 
   
Health Care REIT, Inc.
  Delaware
HCRI Pennsylvania Properties, Inc.
  Pennsylvania
HCRI Texas Properties, Inc.
  Delaware
HCRI Texas Properties, Ltd.
  Texas
HCRI Nevada Properties, Inc.
  Nevada
HCRI Louisiana Properties, L.P.
  Delaware
Health Care REIT International, Inc.
  Delaware
HCN Atlantic GP, Inc.
  Delaware
HCN Atlantic LP, Inc.
  Delaware
HCN BCC Holdings, Inc.
  Delaware
HCRI Indiana Properties, Inc.
  Delaware
HCRI Indiana Properties, LLC
  Indiana
HCRI Limited Holdings, Inc.
  Delaware
HCRI Massachusetts Properties Trust
  Massachusetts
HCRI Massachusetts Properties, Inc.
  Delaware
HCRI Holdings Trust
  Massachusetts
HCRI North Carolina Properties, LLC
  Delaware
HCRI Southern Investments I, Inc.
  Delaware
HCRI Tennessee Properties, Inc.
  Delaware
Pennsylvania BCC Properties, Inc.
  Pennsylvania
HCRI Kentucky Properties, LLC
  Kentucky
HCRI Massachusetts Properties Trust II
  Massachusetts
HCRI Maryland Properties, LLC
  Maryland
HCRI North Carolina Properties I, Inc.
  North Carolina
HCRI North Carolina Properties III, Limited Partnership
  North Carolina
HCRI North Carolina Properties II, Inc.
  North Carolina
HCRI Wisconsin Properties, LLC
  Wisconsin
HCRI Mississippi Properties, Inc.
  Mississippi
HCRI Illinois Properties, LLC
  Delaware
HCRI Missouri Properties, LLC
  Delaware
HCRI Surgical Properties, LLC
  Ohio
HCRI Tucson Properties, Inc.
  Delaware
HCRI Investments, Inc.
  Delaware
HCRI Chicago Properties, Inc.
  Delaware
HCRI General Properties, Inc.
  Delaware
HCRI Kansas Properties, LLC
  Delaware
HCRI Tennessee Properties, LLC
  Delaware
HH Florida, LLC
  Delaware
HCRI New Hampshire Properties, LLC
  Delaware
HCRI Provider Properties, LLC
  Delaware
1920 Cleveland Road West, LLC
  Delaware
721 Hickory Street, LLC
  Delaware
111 Lazelle Road East, LLC
  Delaware
5166 Spanson Drive SE, LLC
  Delaware
1425 Yorkland Road, LLC
  Delaware
222 East Beech Street — Jefferson, L.L.C.
  Delaware
HCRI Senior Housing Properties, Inc.
  Delaware
209 Merriman Road, L.L.C.
  Delaware
HCRI Financing, Inc.
  Delaware

11

EX-10.4 3 l26083aexv10w4.htm EX-10.4 exv10w4
 

EXHIBIT 10.4
HEALTH CARE REIT, INC.
Stock Option Agreement
     THIS AGREEMENT, dated December 20, 2006, between Health Care REIT, Inc., a Delaware corporation (the “Company”), and Daniel R. Loftus (the “Participant”), is made pursuant and subject to the provisions of the 2002 Stock Incentive Plan (the “Plan”) of Windrose Medical Properties Trust, a Maryland real estate investment trust (the “Trust”), a copy of which has been made available to the Participant. All capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed to them in the Plan, except that references in the Plan to the “Company” shall mean “Health Care REIT, Inc., a Delaware corporation” and references to the “Common Stock” shall mean “the common stock, $1.00 par value per share, of Health Care REIT, Inc.”
     WHEREAS, the Trust and Windrose Medical Properties, L.P., a Virginia limited partnership (the “Operating Partnership”), entered into an Agreement and Plan of Merger, dated September 12, 2006, with the Company, Heat Merger Sub, LLC, a Delaware limited liability company (“Merger Sub”), and Heat OP Merger Sub, L.P., a Virginia limited partnership (“OP Merger Sub”), as amended by Amendment No. 1 to Agreement and Plan of Merger, dated October 12, 2006 (the “Merger Agreement”), which provides for: (a) the Trust to merge with and into Merger Sub, with Merger Sub continuing as the surviving entity, and (b) OP Merger Sub to merge with and into the Operating Partnership, with the Operating Partnership continuing as the surviving entity.
     WHEREAS, pursuant to Section 6.2 of the Merger Agreement, each option to acquire common shares of beneficial interest in the Trust, $0.01 par value per share, held by Participant prior to the Merger Effective Time (as defined in the Merger Agreement), became fully vested in accordance with the Plan and is identified on Exhibit A (a “Pre-Conversion Option”).
     WHEREAS, pursuant to Section 6.2 of the Merger Agreement, at the Merger Effective Time, each Pre-Conversion Option was converted into an option to acquire the number of shares of common stock, $1.00 par value per share, of the Company, as reflected on Exhibit A (“Common Stock”).
1. Converted Options. Pursuant to the Plan, the Trust granted to the Participant the Pre-Conversion Options, subject to the terms and conditions of the Plan and the applicable stock option agreement between the Trust and Participant. At the Merger Effective Time, such Pre-Conversion Options were fully vested and converted into an option to acquire the number of shares of Common Stock identified on Exhibit A (the “Converted Options”). Accordingly, effective as of the date hereof and subject to the terms and conditions of the Plan and the terms and conditions herein set forth, Participant shall have the right and option to exercise such Converted Options and purchase from the Company all or any part of the Common Stock at the option price set forth on Exhibit A. The Converted Options are intended to be “incentive stock options” under Section 422 of the Code. Such Converted Options will be exercisable as hereinafter provided.
2. Expiration Date. The Converted Options shall expire at 11:59 p.m. on the applicable Expiration Date set forth on Exhibit A.

 


 

3. Exercisability. The Converted Options shall continue to be exercisable until the earlier of the termination of the right to exercise the Converted Options pursuant to paragraph 6, 7 or 8 or until the Expiration Date. The Participant may exercise the Converted Options for all or part of the number of shares of Common Stock. A partial exercise of the Converted Options shall not affect the Participant’s right to exercise the Converted Options with respect to the remaining shares of Common Stock, subject to the conditions of the Plan and this Agreement.
4. Method of Exercise and Payment for Shares. The Converted Options shall be exercised by written notice delivered to the attention of the Company’s Secretary at the Company’s principal executive office. The exercise date shall be (i) in the case of notice by mail, the date of postmark or (ii) if delivered in person, the date of delivery. Such notice shall be accompanied by payment of the option price in full, in cash or cash equivalent acceptable to the Compensation Committee of the Company, or by the surrender of shares of Common Stock with an aggregate Fair Market Value (determined as of the preceding business day) which, together with any cash or cash equivalent paid by the Participant, is not less than the option price for the number of shares of Common Stock for which the Converted Option is being exercised.
5. Nontransferable. The Participant’s rights under the Converted Options are nontransferable except by will or the laws of descent and distribution. During the Participant’s lifetime, the Converted Options may be exercised only by the Participant.
6. Exercise in the Event of Death. The Converted Options may be exercised by the Participant’s estate, or the person or persons to whom his rights under the Converted Options shall pass by will or the laws of descent and distribution, if the Participant dies before the Expiration Date and before the termination of his or her rights under paragraph 7 or 8. The Participant’s estate or such persons may exercise the Converted Options during the 90 day period following the Participant’s death or, if shorter, during the remainder of the period preceding the Expiration Date. The Participant’s estate or such persons may exercise the Converted Options for all or part of the number of shares of Common Stock that the Participant was entitled to purchase on the date of his or her death.
7. Exercise by Participant After Termination. The Converted Options may be exercised by the Participant if his or her employment with the Company or its Affiliates terminates or is terminated before the Expiration Date and before the termination of his or her rights under paragraph 8. In that event, the Participant may exercise the Converted Options during the 90 day period following the last day that he or she is employed by the Company or an Affiliate or, if shorter, the remainder of the period preceding the Expiration Date. The Participant may exercise the Converted Options for all or part of the number of shares of Common Stock that the Participant was entitled to purchase on the last day that he or she was employed by the Company or an Affiliate.
8. Breach of Covenant. The Converted Options may not be exercised on or after the date that the Participant breaches a covenant against competition, disclosure of confidential information or solicitation of employees contained in a written agreement between the Company and the Participant or an Affiliate and the Participant. In addition, in the event of any such breach, the Participant or the transferee of the Converted Options must return to the Company any shares of Common Stock acquired upon the exercise of the Converted Options within the six

-2-


 

month period before such breach or on or after such breach. Upon delivery of the shares of Common Stock pursuant to the preceding sentence, the Company shall pay the Participant or transferee the option price paid to acquire such shares of Common Stock under the Converted Options.
9. Fractional Shares. Fractional shares shall not be issuable hereunder, and when any provision hereof may entitle the Participant to a fractional share such fraction shall be disregarded.
10. Change in Capital Structure. The terms of the Converted Options shall be adjusted as the Board of Directors of the Company determines is equitably required in the event the Company effects one or more stock dividends, stock split-ups, subdivisions or consolidations of shares or other similar changes in capitalization.
11. Governing Law. This Agreement shall be governed by the laws of the State of Maryland; provided, however, that the issuance of shares of Common Stock shall be governed by the laws of the State of Delaware.
12. Conflicts. In the event of any conflict between the provisions of the Plan as in effect on the date hereof and the provisions of this Agreement, the provisions of the Plan shall govern. All references herein to the Plan shall mean the Plan as in effect on the date hereof.
13. Participant Bound by Plan. The Participant hereby acknowledges that a copy of the Plan has been made available to the Participant and agrees to be bound by all the terms and provisions thereof.
14. No Right to Continued Employment. The Converted Options do not confer upon the Participant any right with respect to continuance of employment with the Company or an Affiliate and does not interfere with the right of the Company or an Affiliate to terminate the Participant’s employment.
15. Binding Effect. Subject to the limitations stated above and in the Plan, this Agreement shall be binding upon and inure to the benefit of the legatees, distributees, and personal representatives of the Participant and the successors of the Company.
16. Superceding Agreement. This Agreement supercedes all other agreements that evidence Pre-Conversion Options.
[SIGNATURE PAGE FOLLOWS]

-3-


 

     IN WITNESS WHEREOF, the Company has caused this Agreement to be signed by a duly authorized officer, and the Participant has affixed his or her signature hereto as of the date first written above.
         
Health Care REIT, Inc.   Daniel R. Loftus
 
       
 
       
By:
  /s/ Erin C. Ibele   /s/ Daniel R. Loftus
 
       
Name:
  Erin C. Ibele    
Its:
  Senior Vice President—Administration    
 
  and Corporate Secretary    

-4-


 

DAN LOFTUS
EXHIBIT A
INCENTIVE STOCK OPTIONS
                                                         
    Vested Before     Vested After                                  
    Merger of 12/19/2006     Merger of 12/19/2006     Total             Exercise Price     Exercise Price        
Grant Date Of   Number of     Number of     Number of Pre-     Number of     Per Share for     Per Share for        
Pre-Conversion   Pre-Conversion     Pre-Conversion     Conversion     Converted     Pre-Conversion     Converted     Expiration  
Options   Options     Options     Options     Options     Options     Options     Date  
8/16/2002
    6,000             6,000       2,705     $ 12.00     $ 26.61       8/15/2012  
8/5/2003
    6,000       1,500       7,500       3,381     $ 12.00     $ 26.61       8/4/2013  
7/27/2004
    4,280       2,853       7,133       3,216     $ 12.00     $ 26.61       7/26/2014  
7/26/2005
    1,000       1,500       2,500       1,127     $ 15.11     $ 33.51       7/25/2015  
NON-QUALIFYING STOCK OPTIONS
                                                         
    Vested Before     Vested After                                  
    Merger of 12/19/2006     Merger of 12/19/2006     Total             Exercise Price     Exercise Price        
Grant Date Of   Number of     Number of     Number of Pre-     Number of     Per Share for     Per Share for        
Pre-Conversion   Pre-Conversion     Pre-Conversion     Conversion     Converted     Pre-Conversion     Converted     Expiration  
Options   Options     Options     Options     Options     Options     Options     Date  
7/27/2004
    220       147       367       165     $ 12.00     $ 26.61       7/25/2014  
12/20/2005
    7,200       28,800       36,000       16,232     $ 14.79     $ 32.80       12/19/2015  
7/26/2005
    4,000       6,000       10,000       4,509     $ 15.11     $ 33.51       7/25/2015  
8/1/2006
    3,600       14,400       18,000       8,116     $ 14.70     $ 32.60       7/31/2016  

-5-

EX-31.1 4 l26083aexv31w1.htm EX-31.1 EX-31.1
 

EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
I, George L. Chapman, certify that:
1.   I have reviewed this quarterly report on Form 10-Q of Health Care REIT, Inc.;
 
2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
  (a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  (b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  (c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
  (d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
  (a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
  (b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 10, 2007
         
     
  /s/ George L. Chapman    
  George L. Chapman,   
  Chief Executive Officer   
 

 

EX-31.2 5 l26083aexv31w2.htm EX-31.2 EX-31.2
 

EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
I, Scott A. Estes, certify that:
1.   I have reviewed this quarterly report on Form 10-Q of Health Care REIT, Inc.;
 
2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
  (a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  (b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  (c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
  (d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
  (a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
  (b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 10, 2007
         
     
  /s/ Scott A. Estes    
  Scott A. Estes,   
  Chief Financial Officer   
 

 

EX-32.1 6 l26083aexv32w1.htm EX-32.1 EX-32.1
 

EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
     I, George L. Chapman, the Chief Executive Officer of Health Care REIT, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended March 31, 2007 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
 
  /s/ George L. Chapman
 
George L. Chapman,
Chief Executive Officer
Date: May 10, 2007
   
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-32.2 7 l26083aexv32w2.htm EX-32.2 EX-32.2
 

EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
     I, Scott A. Estes, the Chief Financial Officer of Health Care REIT, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended March 31, 2007 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
 
  /s/ Scott A. Estes    
 
 
 
Scott A. Estes,
Chief Financial Officer
Date: May 10, 2007
   
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

-----END PRIVACY-ENHANCED MESSAGE-----